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Chaprer 1 
1.1 Introduction 
Iron is the most abundant metal in the universe and the fourth most common 
element on earth (1). It is essential for all known life forms, with the possible exception of 
a few micro-organisms. Depending on the ligand it is linked to, iron has access to a wide 
range of redox potentials. It is involved in the redox reactions of the cell, especially in 
those reactions implying molecular oxygen formation and the release of chemical energy 
for use in the energy-requiring processes of life. 
Iron-containing proteins can be subdivided into 3 classes (1,2): 
Iron-sulphur proteins 
These proteins contain one or more iron atoms ligated by sulphur. The proteins are 
all involved in electron transfer, although this is by no means their only function. 
Examples of the iron-sulphur proteins are: succinate dehydrogenase, NADH-Q 
reductase, aconitase. 
2 Haem proteins 
Haem proteins are distinguished by protoporphyrin prosthetic groups containing a 
central iron atom. Haem proteins have a variety of properties and can be found 
throughout the whole animal and plant kingdom. Examples are: haemoglobin, 
myoglobin, cytochromes, peroxidases. 
3 Non haem and non iron-sulphur proteins 
Many iron containing proteins can not be classified in one of the two groups 
mentioned above. Some examples are: transferrin (Tf), ferritin, superoxide 
dis mutase, dioxygenases. 
In spite of the profusion of the element in the biosphere, the availability of iron for 
living cens is strongly diminished by the poor solubility of Pe(III). In an aqueous and 
aerobic environment the solubility product of Fe(OH)3 is 4xlO-38. This mediocre 
solubility of iron has made it necessary for nature to evolve systems capable of binding 
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iron, to provide for relatively high iron concentrations in body fluids of living organisms. 
Disregarding a few exceptions such as Lactobacillus (3), al1 micro-organisms need 
iron in order to survive. Bacteria therefore have developed a range of low-molecular-
weight iron chelators known as siderophores (4). These siderophores have a high affinity 
for Fe(III) and chelate and solubilize the metal out of minerals and organic substrates. 
Bacteria synthesize and secrete siderophores according to their iron requirement. Specific 
receptors on the bacterial surface bind the iron-siderophore complex and either the 
complex is absorbed by the cell, or the iron is channeled across the membrane. 
Higher plants on the other hand have developed a variety of methods to acquire 
iron from the environment. Like bacteria they also secrete low-molecular-weight iron 
chelators known as phytosiderophores. The affinity for iron of the phytosiderophores is 
lower than of their bacterial equivalent. Plants, however, also secrete acid or reducing 
substances into the soil, both increasing the solubility of iron (5). 
Vertebrates have access to a far more soluble and available iron; as a result of their 
diet they do not need to secrete low-molecular-weight iron chelators. On the other hand, 
these large and complex higher organisms do face another problem i.e. how to transport 
the potentially insoluble iron in the body to the different compartments of utilisation 
and/or storage. For this purpose all vertebrates possess large quantities of an iron-
transporting protein in their blood plasma. This protein, transferrin (Tf), is a member of 
the siderophilin family (2). 
1.2 The siderophilins 
The siderophilins, also known as transferrins, are monomeric iron binding proteins 
dependent on concomitant binding of a suitable anion, generally bicarbonate. This 
cooperative binding between anion and metal ion is an almost absolute requirement, as 
neither of them reacts strongly without the other (6). 
In general the transfelTins have two iron-binding sites and a molecular weight of 
approximately 80 kDa, although this may vary between 40 kDa for Pyura stolonifera Tf 
(7) and 150 kDa for crab Tf. Predominantly they have two domains, the N~terminal and 
the C-terminal domain, the latter bearing one or more N-linked glycans. A unique feature 
3 
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of most of the siderophilins is the display of a salmon-pink color as a result of iron 
binding. Consequently the proteins show an absorbance maximum at 465nm. The major 
siderophilins are: 
TransfelTin 
Transferrin (Tf) has been isolated and partially characterized by Schade and 
Caroline (8) from human plasma and by Laurell and Ingelman (9) from pig plasma. 
Tf was found in the plasma of all vertebrates investigated, including amphibia, 
birds, fish, mammals and reptiles (10,11,12). Tf was also detected in a variety of 
biological fluids like lymph, amniotic fluid and cerebrospinal fluid. Tf is mainly 
synthesized in the liver, but also in the central nervous system, testis, ovary, 
placenta, thymus and lymphocytes. The main function of Tf, as the name indicates, 
is the transport of iron. Moreover, it has antimicrobial properties. 
2 Ovotransferrin 
Ovotransferrin was identified in 1900 by Osborne and Campbell (13) and initially 
named conalbumin, the iron binding capacity of ovotransferrin has been discovered 
at the end of the Second World War by Schade and Caroline (14). Ovotransferrin 
can be found in the egg white of birds and reptiles, where it accounts for 10% of 
the proteins found in the egg white. Within these species the composition of ovo-
transferrin and Tf only differs in the composition of the glycans, the proteins are a 
product of the same gene locus. This similarity was first demonstrated in chickens 
(15). 
3 Lactoferrin 
Lactoferrin has been described first by Johansson in 1958 (16). Lactoferrin can be 
found in milk. In human milk it can account for up to 30% of the total protein 
content, in cow milk for approximately 10%. Human Tf and lactoferrin are not 
related like chicken ovotransferrin and chicken Tf (17). Lactoferrin, like Tf, bears 
two N-linked glycans, but lactoferrin bears one on the C-terminal domain and one 
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on the N-terminal domain, whereas Tf bears both glycans on the C-telminal 
domain (18). Another difference is found in the affinity of both proteins for iron, 
the affinity of lactoferrin being 300 times higher than that of Tf. The function of 
lactoferrin probably is the transport of dietary iron from mother to child. Lactofer-
rin also has a strong antimicrobial quality. 
4 Melanotransferrin 
In 1982 a glycoprotein (p97) has been isolated and partly sequenced from 
melanoma tumour cell membranes (19). The sequence showed homology with Tf, 
moreover antibodies directed against p97 cross-reacted with Tf. The protein has the 
ability to bind iron. It has a molecular weight slightly over 80 kDa and it has an 
extra sequence of 25 hydrophobic aminoacids at the C-terminal end compared to 
Tf. 
All known transferrins are glycoproteins, with the exception of the serum 
transferrins of some fish species belonging to the Cyprinidae (20,21). 
1.3 General considerations on glycoproteins 
Glycoproteins are a diverse group of complex macromolecules, best defined as 
conjugated proteins containing a prosthetic group of one or more covalently bound 
heterosaccharides. They are present in nearly all life fonns. Bacteria, however, do not 
contain glycoproteins, with the exception of the genus Halobacterium and Bacillus 
stearothennaphilus NRS 2004134 (22). 
Glycoproteins cover several classes of proteins such as transport proteins (e.g. transferrin), 
immunoglobulins, hormones and enzymes. 
Although known for nearly one and a half century, the glycan moieties on proteins 
have been ignored until the 1960s. The discovery that protein-bound carbohydrates playa 
role in biological recognition such as in host-pathogen, cell-cell and cell-molecule 
interactions has focused an enormous interest on glycoproteins. The finding that the 
glycans could vary in different developmental or pathological states also has contributed to 
5 
Chapter 1 
an increasing scientific interest in glycoproteins (22,23,24). 
Presumably the glycan moieties of glycoproteins can encode biological informatioo 
that can be decoded by other proteins known as lectins (25). 
The majority of thc glycoproteins secreted by eukaryotic cells contain N-linked 
oligosaccharides. Thcse asparagine-linked glycans can be divided ioto 3 types; the high 
mannosc-, the hybrid- and the complex type (fig I). Serum Tf contains two glycans of the 
complex typc. 
A B C 
R3 R3 
"f Y 
- ASN - - ASN - - ASN -
Figure I The structures of the typical asparagine-linked glycans: the high mannose 
(A), the hybrid (B) and the complex (C) type of oligosaccharides. The symbols 
represent: l] N-acetylglucosamine, • mannose 
R2 ± N-acetylglucosamine ± galactose ± sialic acid 
R3 ± galactose ± sialic acid. 
All N-Iinked oIigosaccharides are synthesized via a common pathway. This 
pathway can be subdivided into 3 subsequent parts, i.e. the rough endoplasmic reticulum 
(RER), the Golgi apparatus and the trans-Golgi network (26,27). The first step in the 
biosynthesis of asparagine-linked oligosaccharides is the cotranslationaI transfer of an 
oligosaccharide by oligosaccharyltransferase from the dolichol-linked oligosaccharide 
GIcO_3ManS_9GIcNac2-(P04)rdolichol to asparagine residues in nascent polypeptides In 
the rough endoplasmic reticulum (28,29). In fact, the oligosaccharidc is linked to 
asparagine residues in the tripeptide -Asn-X-SerIThr. However, less than half of the known 
tripeptide sequences in secreted glycoproteins are glycosylated, possibly due to differences 
in accessibility. 
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Once the oligosaccharide is transferred to the protein it becomes subject to removal 
of glycoside residues by a number of glycosidases. This trimming mainly occurs in the 
ER, transitional ER and the cis-Golgi apparatus. In both the cis- and medial-Golgi 
apparatus the processed oligosaccharide is elongated by addition of other glycoside 
residues. This elongation with additional glycosides and other constituents is continued in 
the trans-Golgi apparatus and the trans-Golgi network. The pathway for the biosynthesis of 
Asn-linked oligosaccharides is shown in figure 2. 
1.4 Transferrin 
Transferrin (Tf) is the fourth most abundant plasma protein in man. Except in 
blood the protein can also be found in several other body fluids including lymph, 
cerebrospinal fluid, tears, saliva, amniotic fluid and seminal fluid. Tf is a monomeric 
protein consisting of 679 aminoacids and a calculated molecular mass of 79,570 Da. As 
discussed earlier, the major function of Tf is transpOlting iron in the circulation. The 
protein consists of 2 domains, the N-tenninal- and the C-tenninal domain. Both domains 
are capable of binding I Fe(III) atom. The affinity constant is I x 1 022 M-1 and 6x 1022 
M-1 for the N- and the C-terminal domain respectively (30). Tf is also capable of binding 
a whole range of other metals like aluminium, gallium, chromium, manganese, cobalt, 
nickel, copper, zinc, cadmium and even plutonium (31-38). With the binding of iron, the 
concomitant binding of an anion is also required (39,40). In a few cases Tf might playa 
physiological role in the transport and binding of a nutritionally essential element other 
than iron, such as zinc and manganese. In other cases Tf may participate in the accumula-
tion of toxic metals. 
In a healthy person serum Tf is about 30% saturated with iron. Under pathological 
conditions such as haemochromatosis this can raise to 100% (41). 
The aminoacid sequence of Tf has been determined (42,43). A striking feature of 
this sequence is the similarity between the N-terminal and C-terminal domain of the 
protein. Approximately 40% of the aminoacids in the N-terminal domain (residues 1-336) 
have identical counterparts in the C-terminal domain (residues 337-679). It has been 
suggested that the Tf gene is the product of an intragenic gene duplication (44). 
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Figure 2 Schematic pathway of the biosynthesis of Asn-linked oligo saccharides. 
The biosynthesis is initiated in the rough endoplasmic reticulum (RER) and 
proceeds through the cis-, medial- and trans-Goigi apparatus_ The reactions are 
catalyzed by the following enzymes (I) oligosaccharyltransferase, (2) a-gluco-
sidase I, (3) a-glucosidase II, (4) ER a 1 ,2-mannosidase, (1) N-acetylgluco-
saminylphosphotransferase, (II) N -acetylglucosamine-l-phosphodiester a -N-
acetylglucosaminidase, (5) Golgi a-mannosidase I, (6) N-acetylglucosarninyl-
transferase 1, (7) Goigi a-mannosidase 11, (8) N-acetylglucosaminyltransferase II, 
(9) fucosyltransferase, (10) galactosyltransferase, (11) sialyltransferase. The 
symbols represent: 11 N-acetylglucosamine, • mannose, 1'1 glucose, .It.. fucose, • 
galactose, 0 sialic acid. Adapted ITom Kornfeld (26) 
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The advantage is obvious, enlarging the protein prevents losing both iron and protein 
through glomerular ultrafiltration. Two other members of the human siderophilin family, 
lactoferrin and melanotransferrin, also show a similar degree of internal homology 
between the N-terminal and C-terminal domain. 
The C-Iobe carries two N-linked oligosaccharide chains attached to the asparagine 
residues 413 and 6] 1. These "complex type" glycans are highly variable and contribute to 
the so called microheterogeneity of Tf. The glycans can differ in the degree of branching; 
biantennary, triantennalY and even tetraantennary structures have been shown to exist (fig 
3, 124). 
N C 
Figure 3 Schematic representation of the human Tf molecule. The N-terrninal-
and C-terminaJ domain are both capable in binding 1 Fe(III) atom. The C-terminal 
domain carries two glycans. Bi-bi-, bi-tri- and tri-tri antennary Tfare shown_ 
The sialic acids on the glycans contribute substantially to the isoelectric point of 
Tf. Therefore Tf can be separated according to the amount of sialic acid by a technique 
called isoelectric focusing (IEF). Subfractions of Tf isolated by means of IEF can contain 
Tf bearing all possible branched glycan variants, because the glycans can be partly desia-
Iylated. The isoelectric point of Tf varies between pH 5 to 6. 
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1.5 The significance of transferrin glycans 
Specific variations in the oligosaccharide moieties of Tf are known to occur in 
several (patho)physiological conditions, for instance pregnancy, rheumatoid arthritis, 
malignancies and alcohol abuse (45-54). 
During pregnancy a shift towards the higher branched (and higher sialylated) 
glycans has been reported in humans and in guinea pigs (45,48,49). An increased affinity 
of the transfenin receptor (TfR) for Tf bearing higher branched glycans was reported by 
Rudolph (55), However this could not be confirmed by other autors (45,46,56), Regarding 
guinea pigs, Van Dijk et al. (46) report, the changes seen in the Tf glycans during preg-
nancy do not seem to be functionally related to maternal or fetal erythropoiesis. 
The changes in the Tf glycans due to malignancies are more variable. Increased 
branching, fucosylation and bisecting of the glycan chains (fig. 4) have been reported. 
Figure 4 Biantennary complex-type glycan with fucosylation and bisecting N-
acetylglucosamine. The symbols represent: 0 N-acetylglucosamine, • mannose, 
A fucose, .. galactose and 0 sialic acid 
In alcoholism, the 2-siaiylated Tf subfraction increases at the expense of the higher 
sialyiated Tf subfractions. Figure 5 shows the normal distribution of the sialo-transferrin 
subfractions. 
10 
Introduction 
4 
\ 
3 
2 
Figure 5. The normal distribution of the sialo-transferrin subfractions. The insert shows 
the separation of Tf into different sial a-transferrin subfractions on an IEF geL 
The shift of biantennary glycans towards tri- and tetra-antennary glycans on Tf in 
humans has not only been reported during pregnancy, but also during the course of liver 
cirrhosis (57,58). In case of the latter (pathological) situation, a similar shift has been 
described for alpha-I-acid glycoprotein (59). Since cirrhosis of the liver renders this organ 
chronically hypoxic (60), it was suggested that hypoxia affected the glycosylalion of n. 
However, this could not be demonstrated in rats kept under hypoxic conditions (61). 
Rat Tf bears only one glycan. Removal of this glycan results in reduced hepatic 
11 
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iron uptake compared to normal Tf. The affinity for iron and the kinetics of iron release 
from the N~lobe and C~lobe however, is not affected by the deglycosylation of rat Tf (62). 
The oligosaccharide moieties of glycoproteins can be of importance to the 
intracellular transpOlt of these proteins during synthesis. Tf is one of the exceptions, in 
which absence of the glycans does not influence the rate of intracellular transport during 
synthesis (63). 
1.6 Production of aglycotransferrin 
To tackle the intriguing question whether or not Tf glycans serve any physiological 
function, it is necessary to compare Tf with nonglycosylated Tf. Theoretically nonglycosy-
lated Tf can be obtained by deglycosylation of Tf. In general protein deglycosylation is 
either performed by chemical methods with anhydrous hydrogen fluoride or by enzy-
matical methods with endo- or exoglycosidases. 
Treatment of nonglycosylated lysozyme and RNase as well as glycosylated 
ovomucoid with anhydrous hydrogen fluoride has shown that these proteins can retain 
their biological function after such a treatment. Unfortunately G1cNac-Asn linkages are not 
cleaved by anhydrous hydrogen fluoride treatment (64,65,66) making this method not 
applicable for Tf. 
The use of endoglycosidases for enzymatically cleaving the glycan chains at their 
base, is widespread. Best results are obtained with proteins after denaturation by sodium 
dodecyl sulfate (SDS)(67,68,69), rendering these proteins unsuitable for biological studies. 
However, some authors have reported enzymatical deglycosylation without prior denatura-
tion (70,71). In any case endoglycosidases are very expensive, therefore the production of 
a fair quantity of deglycosylated Tf would be a very valuable enterprise. 
An alternative for deglycosylation of Tf is the production of nonglycosylated Tf. 
This can either be performed by blocking the glycosylation of Tf during synthesis with 
tunicamycin (18,72), by producing nonglycosylated Tf in eukaryotic cells using site-
directed mutagenesis (73) or by production of the human protein in a bacterial expression 
system (74-77). Bacteria lack the rough endoplasmic reticulum and the Goigi system and 
are therefore not able to attach N-linked glycans to their products. The two first-mentioned 
12 
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methods are not suitable to obtain large quantities of nonglycosylated Tf in contrast to the 
third method. 
Gene expression in the cytoplasm of Escherichia coli characteristically results in 
the accumulation of levels of recombinant protein ranging up to 25% of the total cell pro-
tein (64). A drawback of overexpressing proteins in prokaryotic organisms is that the poly-
peptide chains are often produced in an insoluble' and biologically inactive fonn, clustered 
in inclusion bodies (fig. 6). 
The exact mechanism of inclusion body fonnation remains to date unknown. 
Initially this formation was attributed to the generation of an incorrectly transcribed or 
translated sequence (65). However, it turned out that native active proteins could be 
obtained from inclusion bodies by completely unfolding these proteins with strong 
denaturants and subsequently searching for conditions in which refolding occurs (reviewed 
in 64). Furthermore normal Escherichia coli proteins synthesized to high levels using 
recombinant DNA techniques can also accumulate in insoluble fonns (66,78,79). Therefore 
inclusion body formation is neither simply a response to "foreign" proteins, nor just a 
consequence of proteins synthesized to concentrations above their solubility as proteins 
expressed at very low levels also fonn inclusion bodies (80). 
Inclusion bodies are dense and can be sedimented by centrifugation as a first step 
to purify the recombinant proteins from Escherichia coli cell debris after lysis of the cells. 
Subsequently inclusion bodies can be dissolved for instance in 6 M guanidine (81,82,83) 
or 8 M urea (75,84,85). 
In the Escherichia coli cytoplasm reducing conditions do exist (86). When inclusion 
bodies are isolated that contain proteins able to form disulphide bonds, this formation is 
likely to occur as a result of air oxidation. These disulphide bonds can stabilize the 
inclusion bodies and this is undesirable when isolation of proteins from the inclusion 
bodies is intended. Therefore the inclusion bodies should be dissolved under reducing 
conditions, e.g. in the presence of B-mercaptoethanol or dithiothreitoI (DTT). 
13 
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Figure 6. Inclusion bodies (i) in recombinant human transferrin producing Escherichia 
coli. No membrane can be seen around the inclusion bodies. Arrows indicate the double 
layer membrane of the bacteria. The bar represents O.6Jlm. 
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1.7 Renaturation of recombinant proteins 
To be biologically active, proteins have to adopt a specific three-dimensional 
structure, The genetic encoding for a protein however, contains only information on the 
lineair amino acid sequence of that particular protein, but no information for the three-
dimensional conformation, It is believed that the primary structure of proteins contains the 
necessary information for folding into the correct state, as was first suggested by Anfinsen 
(87). During the late 1950s he showed that completely unfolded RNase A with its four 
disulphide bonds cleaved in a 8 M urea solution containing B-mercaptoethanol, could be 
renatured on a quantitative basis by dialyzing away the urea and exposing the solution to 
oxygen. The resulting protein showed nearly 100% enzyme activity and was indistin-
guishable from native RNase, suggesting the protein renatured spontaneously under 
physiological conditions. This spontaneous renaturation is not simply a random search for 
a conformation with the lowest free energy, as this would, even for small proteins, take an 
immense amount of time (88). 
Thus proteins overexpressed in prokaryotes and deposited in inclusion bodies can 
be renatured after dissolving the proteins using chaotropes such as urea or guanidine 
hydrochloride. Removing the chaotropes by means of dilution or dialysis should initiate 
the correct folding compelled by the amino acid sequence of the proteins. Although this 
method gives good yields with small proteins such as lysozyme and RNase, with bigger 
proteins the yield is considerably diminished due to aggregation during the refolding 
process, This aggregation is ascribed to hydrophobic interactions (65,89,90) and to cova-
lent disulphide linkage formation (91). 
Additional factors can reduce or even prevent correct refolding of overexpressed 
proteins. Prokaryotes are unable to perform N-glycosylation of proteins, lack of 
carbohydrates can diminish the refolding of these proteins (92,93). The lack of any 
prosthetic groups if necessary can also impair the refolding (93). Furthermore expression 
of mature proteins that normally are synthesized in eukaryotic cells as larger precursors 
and subseq uently are processed after folding, e.g. insulin, can possibly not be refolded 
after production (94). 
More recently biological "factors" have been discovered facilitating the (re)folding 
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of proteins such as protein-disulphide isomerase (POI) (95,96) that catalyzes disulphide 
interchange reactions and several so called chaperones (97). These chaperon ins can be 
found in all types of cells, in the cytoplasm, the endoplasmic reticulum and mitochondria. 
They are believed to catalyse protein folding and to prevent aggregation (98,99,100). 
Although the intrinsic information of the protein structure in the polypeptide sequence 
remains the basis of present renaturation experiments, the use of chaperonins in 
quantitative refolding procedures can become important in the near future since it has been 
shown that the yield of renaturation experiments increases in vitro (101,102,103). 
1.8 Iron donation by transferrin 
Tf is the major source of iron for human cells. Iron transfer from Tf to the cell is 
initiated by the binding of Tf to the transferrin receptor. After this interaction two iron-
uptake mechanisms are suggested; iron is released from Tf and transported through the 
cell membrane (104,105,106), or the Tf-TfR complex is endocytosed by the cell. In both 
mechanisms the TfR has a central role. The first indications of the existence of a TfR 
were described by Iandl in 1959 (107). 
The TfR is a class II receptor consisting of two identical subunits of 95 kDa each 
(108-111). The subunits are transmembrane glycoproteins containing at least three aspara-
gine linked oligosaccharides; complex type glycans as well as high mannose type glycans 
are found on the mature receptor. The function of these glycans is unknown, but it has 
been suggested that they are involved in the proper folding of the molecule during 
biosynthesis and assembly in the endoplasmic reticulum (112,113,114) as well as the 
transport to the cell surface. The oligosaccharides linked at the TfR also influence the 
affinity for Tf (115,116). 
The bulk of the TfR molecule is exposed on the cell surface and can be cleaved off 
the cell surface with a low concentration of trypsin. The soluble fragment generated this 
way is still able to bind Tf. The TfR subunits are linked by disulphide bonds. Both 
subunits are able to bind one Tf molecule. Tf binds to its receptor with high affinity, the 
dissociation constant of the TfR varies from 5-20 x 10-9 M. The serum concentration of 
Tf is 1.5-2.5 x 10-5 M, so the transferrin receptors should be continuously saturated with 
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its ligand. Figure 7 shows a schematic representation of a TfR. 
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Figure 7 Schematic representation of the transferrin receptor The transferrin 
receptor is a dimer fonned by two identical 95 kDa polypeptide structures and linked 
by disulphide bonds. Each monomer can bind one transferrin molecule. 
Legend: 1: N-linked glycans of the high mannose type; 2 N-linked glycans of the 
complex type; 3: O-linked glycans; P: phosphorylation site; T: trypsin cleavage site; 
NV\NV : palmitic acid, covalently bound to the receptor. 
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Several authors have suggested that iron can be released from Tf by a reductive 
process at the cell surface (117,118,119). More important is the iron uptake by means of 
"receptor mediated endocytosis". This process is initiated by the binding of Tf to its 
receptor. It is believed that the primary receptor-recognition site is situated in the C-
terminal lobe of Tf (120). The transferrin receptors are concentrated in clathrin-coated pits. 
At physiological pH the affinity of the TfR is much higher for diferric Tf than for 
monoferric- or apotransferrin, ensuring an effective use of the transferrin receptors. The 
clathrin-coated pit folds into a vesicle and becomes internalized into the cytoplasm. Once 
internalized, the coated vesicles lose their clathrin coat and become rapidly acidified by 
means of a proton-pump. Lowering the pH to values ranging between 5 and 6 serves 
several purposes. 
Firstly, the acidification facilitates the release of iron from Tf. However, it takes 
several hours before total release of iron from Tf is achieved in an environment with a pH 
of 5.5. Since the endocytosis/exocytosis cycle of Tf is only a matter of minutes (121), it 
has been suggested by several authors that the TfR plays a crucial role in the release of 
iron from Tf under these conditions (122,123). The released iron is subsequently removed 
from the endosome by unknown mechanisms. 
Secondly, lowering the pH creates reversible conformational changes of the TfR 
(124). These changes could induce protease insensitivity and could be of importance of 
segregating the TfR from other receptors. 
Finally the acidification also increases the affinity of the TfR for apotransferrin 
ensuring the binding and subsequent transfer of this carrier protein to the extracellular 
cavity. This is an important mechanism in the protection of Tf against lysozomal 
degradation. Once exposed to the neutral pH of the extracellular environment, the 
apotransferrin-TfR complex rapidly falls apart, leaving the apotransferrin for another quest 
for iron. 
Regarding the function of the Tf glycans, one other mechanism of iron uptake 
should be considered, i.e. uptake by means of asialoglycoprotein receptors (ASGR). This 
C-type lectin (125) has been described by Pricer Jr. ef al. in 1974 (126) and can be found 
on hepatocytes. It has a high affinity for galactose and N-acetylgalactosamine (127,128) 
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tenninating oligosaccharides of desialylated glycoproteins including partially desialylated 
Tf. Hepatocytes are able to obtain iron through ASGR (129,130). 
Initially it was assumed that Tf which entered the cell via the ASGR was degraded. 
However, it was demonstrated that partially desialylated Tf was exocytosed after entering 
hepatocytes through the ASGR (131). The TfR also plays an important role in this so 
called "diacytosis" (132). Tf even can be resialylated during this process (133,134,135). 
1.9 Aims of this thesis 
Although initially neglected, the presence of oligosaccharides on glycoproteins are 
now a source of intriguing questions. Constantly new data on the micro heterogeneity of Tf 
becomes available but the biological significance of the glycans is still not elucidated. 
With this work we hope to acquire more insight in the influence of the glycans on the 
structure and biological function of Tf. 
Changes in the microheterogeneity of Tf are used as a clinical marker for (gross) 
alcohol abuse. We have investigated the usefulness of this marker for detection of a more 
limited degree of alcohol abuse. 
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Chapter 2 
2.1 Introduction 
This chapter gives an overview of the general techniques used to obtain the results 
described in this thesis. 
All chemicals used were of analytical grade. 
2.2 Preparation and isolation of different transferrin glycovariants 
2.2.1 Introduction 
The bi-bi antennary transferrin (bi-bi TO subfraction was purified from 
commercially obtained transferrin (Tf) (Behringwerke). Bi-bi Tf was step-wise partially 
deglycosylated by the proper exoglycosidases. Following each enzyme incubation, Tf was 
purified by using a Sepharose-bound anti-transfen·in IgG column (1) or by means of 
preparative isoelectric focusing (2,3) and the effect of the deglycosylation was determined 
by carbohydrate analysis (4) or amino acid analysis (5,6). 
Furthelmore aglyco Tf was isolated from a patient suffering from the Carbohydrate 
Deficient Glycoprotein syndrome. 
2.2.2 Isolation of hi-hi antennary transferrin 
The bi-bi Tf subfraction was isolated from the bi-tri- and tri-tri Tf subfractions by 
means of a Sepharose ConA (Pharmacia) column (7). The binding of bi·tri Tf to ConA is 
not as strong as the binding of bi-bi Tf to this lectin. Tri-tri Tf does not bind to ConA at 
all. The ConA column was equilibrated with buffer containing 0.05 M Tris/HCI, I M 
NaCI, I mM CaCI2, I mM MnCI2 and I mM MgCI2 (pH 7.6). This buffer will further be 
referred to as ConA buffer. The binding of bi-tri Tf to a Sepharose Con A column can be 
broken by eluting the column with ConA buffer containing 10 rnM glucose. Bi-bi Tf can 
be eluted from the column by elution with buffer containing 150 mM cx-methyl-glucopy-
ranoside. Figure 1 shows a separation of commercially obtained Tf into tri-tri-, bi-tri- and 
bi-bi Tf subfractions. 
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Figure 1. Fractionation of commercially obtained Tf into tri-tri- (A), bi-tri- (B), and bi-bi 
Tf (C) subfractions. Arrows indicate buffer changes to respectively ConA buffer 
containing 10 mM glucose and ConA buffer containing 150 mM a-methyl-gluco-
pyranoside. 
2.2.3 Stepwise enzymatic deglycosylation of hi-bi antennwy transferrin 
2.2.3.1 Neuram inic acid removal 
For this purpose, bi-bi Tf was incubated at 3rC with Clostridium pelfringens 
neuraminidase EC 3.2.1.18 (type X, Sigma) in sodium-citrate buffer (50 mM, pH 5.0) for 
at least 24 hours in a ratio of 1 mU enzyme/mg Tf, giving rise to partially and totally 
desialylated Tf subfractions. 
35 
Chapter 2 
The asialo Tf subfraction was isolated from this mixture by preparative isoelectric 
focusing (2) on an Ultrodex gel (Phannacia, LKB) as described below (2.2.5). 
2.2.3.2 Galactose removal 
The asialo Tf subfraction was incubated with Diplococcus pneumoniae B-
galactosidase (EC 3.2.1.23, Boehringer Mannheim) for at least 24 hours. In our 
experiments longer incubation times with a lower enzymelTf ratio yielded better results. 
Dialysis of the enzyme/Tf mixture during incubation also improved the results. Incubations 
were performed in sodium-citrate buffer (50 ruM, pH 6.5) at 3rC, using 2.5 mU 
enzyme/mg Tf. 
Following incubation the agalacto Tf was isolated by preparative isoelectric 
focusing (see 2.2.5) and the galactose content was determined. A decrease in the galactose 
content of 95% or more compared to bi-bi Tf was considered successful, otherwise the 
enzyme incubation and isolation were repeated. 
2.2.3.3 Removal of the distal glucosamine 
The agalacto Tf subfraction was incubated with Diplococcus pneumoniae N-acetyl-
B-D-glucosaminidase (EC 3.2.1.30, Boehringer Mannheim) at 37°C in sodium-citrate 
buffer (50 mM, pH 4.8) for at least 24 hours. As with B-galactosidase, longer incubations 
yielded better results. The incubation was performed with an agalacto Tf concentration of 
approximately 20 mg/ml and 30 mU enzyme/mg Tf. 
After the incubation this glucosamine deficient Tf was purified by sepharose-bound 
anti-transferrin IgG affinity chromatography (see 2.2.5.) and is henceforward referred to as 
aglucosamine Tf. The effectivity of the incubations was examined by determining the 
glucosamine content. 
2.2.4 Isolation of carbohydrate deficient transferrin 
Aglyco Tf was isolated from a patient suffering from Carbohydrate Deficient 
Glycoprotein syndrome by means of Sepharose-bound anti-transferrin IgG affinity 
chromatography and preparative isoelectric focusing (see 2.2.5.). Complete lack of glycans 
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in this isolated subfraction was demonstrated by carbohydrate analysis. 
2.2.5 Purification of partially deglycosylated transferrin 
The partially deglycosylated transferrins were purified using several methods: 
preparative isoelectric focusing in an Ultrodex gel (Pharmacia) or in an Immobiline gel 
(Pharmacia) or by means of affinity chromatography. The application of these different 
purification methods was merely based on the disparity in the amount of protein that could 
be purified in one time. 
2.2.5.1 Preparative isoelectric focusing in an Ultrodex gel 
A 4% U1trodex gel was prepared with a 5% Ampholine solution (Ampholine 
Carrier Ampholytes 5-8) and poured into a tray placed on an exactly horizontal table. The 
excess of water was evaporated from this suspension using a small blow-drier and this 
process was carefully monitored by regularly weighing of the gel. Thereupon the gel was 
placed on a Multiphor cooling plate (Phannacia) and the electrode strips were placed on 
the gel, the anodic strip soaked in 1 M phosphoric acid and the cathodic strip soaked in I 
M sodium hydroxide (8). The gel was prefocused for 90 minutes. The maxima of the 
power supply were set on 1200 V, 45 Wand 75 rnA (2). Following the prefocusing an 
electrode strip soaked in Tf/enzyme solution was placed into the gel approximately 1 cm 
above the cathode and this material was focused for approximately 120 minutes. 
Subsequently the asialo Tf containing zone of the gel was transferred into a column with a 
spatula and the protein was eluted from the gel. Using this method several hundred mgs of 
asialo Tf preparations could be purified in one run. 
2.2.5.2 Preparative isoelectric focusing using 1mmobiline DryPlates 
For the purification of smaller amounts of Tf Immobiline DryPlates (pH 5.6 - 6.6) 
were used (3). Prior to the isoelectric focusing, a piece of DryPlate was rehydrated in 
distilled water for 90 minutes. Subsequently the gel was carefully dried using filter paper 
and placed on the cooling bed of a Multiphor (Phannacia). Two electrode strips were 
applied on the gel, the strip on the cathodic site was soaked in 10 m1V1 sodium hydroxide 
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and the strip on the anodic site was soaked in ] 0 mM phosphoric acid. The Tf/enzyme 
solution was applied on the gel near the cathode and the material was focused for several 
hours. When purifying small amounts of Tf subfractions, the zone containing e.g. asialo Tf 
was cut out and the protein was washed out of the gel by placing it in a tube containing 
10 mM sodium bicarbonate. When loading the gel more heavily, the asialo Tf even 
exuded out of the focusing zone (fig.2) and could easily be collected by soaking it into 
electrode strips. 
2.2.5.3 Purification of transferrin subfractions using CNBr-activated Sepharose 4B 
Rabbit anti-human transfen·in IgG was coupled to CNBr-activated Sepharose 4B 
(Pharmacia) as described by Van Eijk (1). This gel was used to perform affinity 
chromatography to separate the Tf from the enzyme solution. The Tf/enzyme solution was 
eluted through the column with phosphate·citrate buffer pH 8.0 containing 0.25 M NaCI. 
Subsequently coupled Tf was washed from the column with phosphate-citrate buffer pH 
2.8 containing 0.25 M NaCI. 
2.2.6. Carbohydrate analysis 
To monitor the result of the enzymatic incubations using B-galactosidase and N-
acetyl-B-D-glucosaminidase, carbohydrate analyses were performed after each enzymatic 
step on purified Tf subfractions. 
For the determination of the galactose content, 100 to 400 JlI aliquots of agalacto 
Tf solution with a known protein concentration were hydrolysed at 100cC in 2 M TFA for 
24 h at pressures < 1 mm Hg. The hydrolysed mixture was evaporated at room 
temperature, the residue then was dissolved in 1O0 JlI distilled water and mixed with 900 
JlI 100% ethanol. The hydrolysate was cleaned up with 6 fll analytical resin suspension 
(Ultra pac II, PharmacialLKB), followed by partition chromatography with a cation· 
exchange resin using 90% ethanol as eluent and tetrazolium chloride as reagent (4). 
N·Acetylglucosamine was determined as glucosamine after special hydrolysis in 3 
M pTSA during 24 h at 110°C and P < Imm Hg, using a slightly adapted amino acid 
analysis program (Biochrom 20, PharmaciaiLKB, Cambridge, UK) (5,6). 
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Figure 2. Isolation of asialo fraction from a bi-bi Tf solution after incubation with 
neuraminidase. The Tf solution is loaded on an Immobiline gel (pH 5.6 - 6.6. A). The 
asialo and monosialo Tf subfractions exude out of the gel during focusing (B) and can 
easily be collected. 
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2.3 Production, isolation and renaturation of recombinant human aglyco~ 
transferrin and its half ~molecules 
2.3. J Introduction 
In the following section the production, isolation and renaturation of recombinant 
aglyco Tf and recombinant N-tenninal and C-terminal half aglyco Tf is described. The 
recombinant proteins are produced by Escherichia coli. 
The construction of the recombinant transferrins producing E. coli strains has been 
described by us (9). In short, for expression purposes the E. coli KI2 strain LCI37 was 
used. This bacterial strain is deficient in heat-shock response (htpR) and in La-protease 
(Zan). A transferrin expression plasmid ptacRRTF3101 was constructed using the following 
plasmids: pPLc2833 (10), pMS2-7 (II) and pTfR27A (12). For the production of the N-
terminal half-transferrin, codon 338 was mutated to a termination codon. For the 
production of C-terminal half-transferrin, the N-tenninal half of the coding sequence was 
removed. Transformation of LC 137 required electroporation, and was perfonned using a 
CellJect Basic apparatus at 2500 V (Eurogentec, Liege). 
Bacteria are not able to attach N-linked glycans to their proteins and could serve 
therefore as a good source of aglyco Tf. The recombinant transferrins are deposited in a 
denatured state in large amorphous particles; inclusion bodies. 
2.3.2 Production of the recombinant aglycotransferrins 
We inoculated 25 ml Luria Complete (LC) medium containing ampicillin (50 ~g/ 
ml) and spectinornycin (100 Ilg/rnl) with one of the recombinant transferrins producing 
Escherichia coli strains. Incubation was performed at 30°C in an air-shaker for approxima-
tely 22 hours. Subsequently this culture was added to 1 L LC medium and incubated for 
another 20 hours under similar conditions. After 2Yz hours however, the Ptac-prornotor was 
induced by adding 0.2 g isopropyl-G-D-thiogalactopyranoside (IPTG,9). 
Finally the cells were collected by centrifugation and stored at -20°C until further 
processing. 
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2.3.3 Isolation of the inclusion bodies from Escherichia coli 
Bacteria harvested from t L LC medium were resuspended in 10 mt lysis buffer 
(see below), 4 mg lysozyme was added and the cells were incubated at room temperature 
for 30 minutes. Subsequently the bacteria were snap-frozen in a mixture of solid CO2 and 
ethanol. The sample was thawed and incubated with approximately 300 U DNase I for 45 
minutes at room temperature. The produced recombinant transferrins are deposited in so 
called inclusion bodies in the bacteria. These inclusion bodies were isolated from the cell 
lysate by centrifugation at 12,000 g for 15 minutes. The pellet was washed 3 times in 
washing buffer (see below) and dissolved in 10 ml dissolving buffer (see below). 
Composition of the used buffers 
Lysis buffer: 
Washing buffer: 
Dissolving buffer: 
50 mM Tris/Hel, I mM EDTA, 250 mM Nael, 5 mM DTT, 5 mM 
sodium bisulfite, pH: 8.0 
50 mM Tris/Hel, I mM DTT, I % Triton X-lOO, pH: 8.0 
8 M urea, I mM DTT, 40 mM Tris/Hel, 10% glycerol, 0.02% NP-
40, pH: 7.6 
2.3.4 Renaturation of the recombinant transferrins 
In general, renaturation was acquired by reoxidizing the reduced recombinant 
proteins in a concentration ranging from 10-20 ~g/ml at 6°C using a glutathione redox 
couple (13-16). Briefly, the protein concentration of the inclusion body solution was 
determined according to the method described by Bradford (17). Next, renaturation was 
initiated by diluting this inclusion body solution in renaturation buffer (0.1 mM Tris/HCI, 
0.1 mM Na-EDTA, 1.0 mM OSH, pH 8.2, 6°C) to a final protein concentration of 
approximately 20 Jlg/ml. The demineralized water used to prepare the renaturation buffer 
was degassed by means of boiling and it was stored under an atmosphere of nitrogen. The 
total volume of renaturation buffer used in one experiment mounted up to 60 L. Next, the 
mixture was incubated for 15 minutes and subsequently OSSG was added to a final 
concentration of 0.5 mM. This solution was incubated for another 22 hours at 6°C. 
After this step the solution was concentrated and dialyzed against 10 mM NaHC03 
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using an Ultrasette with an omega 10 kDa membrane (Filtron). Subsequently the solution 
was filtered over 5 11m low ash polyvinyl chloride membranes (GelmanSciences) and 
concentrated further using successively an Arnicon Stirred Cell with a PM 10 membrane 
and Centrifio CF 25 cones (Amicon). 
2.3.5 Purification of the recombinant transfern·ns 
Due to the fact that the inclusion bodies contain other proteins next to the 
recombinant aglycotranferrins, the latter proteins have to be purified after renaturation. For 
this purpose the renatured proteins were dialyzed against 0.05 M phosphate buffer (pH 
5.5) for 24 hours. As a result a substantial part of the (unwanted) proteins precipitated. 
The suspension was centrifuged at 12,000 g for 15 minutes and the supernatant was 
collected. The pH of the supernatant was adjusted to 8.2 and the recombinant aglyco Tf 
was saturated by adding an excess of iron (FeCI3INTA complex) and 5% NaHC03 (w/v). 
Recombinant aglyco Tf was isolated from this solution by means of Sepharose-bound anti-
transferrin affinity chromatography (see 2.2.4). 
2.4 Labeling of the transferrin subfractions 
The different Tf subfractions (enzymatically partially deglycosylated or from 
recombinant origin) used for binding studies were labeled with 1251 and also with 59Fe 
(Amersham) when used for uptake studies. Labeling with 59pe and 1251 was perfonned as 
described by Starreveld (18). Por iodination, 1 mg of Tf subfraction was incubated with 
1251 (0.83 mCi) for 10 minutes at room temperature in a glass vial coated with 100 flg 
Iodo-Gen (Pierce). Free 1251 was removed with a Sephadex PD-I0 column (Pharmacia) 
followed by extensive dialysis against a 10 mM Tris/HCI buffer (pH S.2) for 3 x 24 hours. 
When doubly labeled Tf subfractions were required, the Tf subfractions were labeled with 
59pe prior to iodination. 
Por the labeling with 59pe, apo-Tf subfractions are required. Apo-Tf was prepared 
by dialyzing Tf against 0.1 M acetate buffer (pH 5.0) containing 0.04 M EDTA. Subse-
quently apo-Tf was dialyzed against distilled water and 10 mM Tris/HCI (pH S.2). 5% 
NaHC03 (w/v) was added before incubating the protein with 59FeINTA in an iron to Tf 
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molar ratio of 3 to 1 for 30 minutes at 3rC. The excess of iron was removed with a 
Sephadex PD-IO column. 
2.5 Cell culture conditions and cell related experiments 
2.5.1 Culturing human hepatoma cells 
The human hepatoma cell line PLC/PRF/5 was obtained from the European 
Collection of Animal Cell Cultures (Salisbury, U.K.). The cells were cultured in cell 
culture flasks (Costar) in a Salvis Biocenter 2001. The cells were grown at 37°C in humi-
dified 5% C02/95% air in Dulbecco's Modification of Eagle's Medium (DMEM, ICN 
Biomedicals) containing 20 mM Hepes. Prior to use we added 10% (v/v) Fetal Bovine 
Serum (FBS, ICN Biomedicals), 4 mM L-Glutamine (Merck) and 0.05 mg/ml Gentamycin 
(Phannachemie B.V.) to this medium. Culture medium was changed every third or fourth 
day. 
2.5.2 Transferrin binding determination 
Approximately 4 days before statting a binding experiment the cells were harvested 
from the culture flasks and disseminated in 35 mm cell culture cluster dishes (Costar). 
Experiments were performed as soon as the cells formed a continuous monolayer. The 
culture medium was removed and the cells were washed twice with PBS of 4°C. To 
minimize the expression of transferrin receptors saturated with endogenous Tf, the cells 
were incubated with PBS of 37°C for 15 minutes and subsequently washed 3 times with 
icecold PBS. The PBS was replaced by incubation medium (DMEM containing 20 mM 
Hepes and 4 mM L-Glutamine). A concentration range from 0.25 ~g/ml to 3 ~g/ml of the 
125r labeled diferric Tf subfractions of interest was added to the dishes and the cells were 
incubated 90 minutes at O°C. 
Nonspecific binding was determined by the following experiment: PLC/PRFI5 cells 
were incubated with 1251 labeled transferrins with a 50 times excess of unlabeled n, the 
latter being of the same subfraction as the type investigated. Following the incubations, the 
cells were washed 3 times with PBS (4"C), lysed by addition of distilled water and 
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collected with a rubber "Policeman". The dishes were rinsed with 0.1 % Triton X-IOO. The 
samples were homogenized by sonication in melting ice for 20 seconds and samples were 
taken for protein determination according to the method described by Bradford (17). 
Surface bound radioactivity was measured with a Packard 500C autogamma spectrometer. 
2.5.3 Transferrin and iron uptake detelm ination 
Iron uptake studies were perfonned in similar culture dishes as the binding studies. 
The cells, fonning a continuous monolayer, were washed twice with PBS (37°C) and 
incubated with incubation medium as used in the binding studies. At t=O doubly labeled 
Tf was added to a final concentration of 3 fJg/ml. At preset times the incubation medium 
was removed and the cells were washed 3 times with icecold PBS. To remove all surface 
bound Tf, the cells were incubated in acetate buffer (25 mM sodium acetate, 0.15 M 
NaCI, 20 mM CaCI2, pH 4.5, 4°C) for 8 minutes followed by a 2 minute incubation in 
PBS (4°C). This procedure was repeated once. Subsequently the cells were lysed and 
collected as described in 2.5,2. Intracellular 59Fe and 1251 were determined with a 
Packard 500C autogamma spectrometer. 
2.6 Protein determination 
Protein concentrations in the samples collected after the different cell incubations 
as described above, and in the inclusion body dissolving buffer (see 2.3.3.) were 
determined according to Bradford (17). Bovine Serum albumin in different concentrations 
was used as a standard. 
2.7 Analytical electrophoresis techniques. 
2.7.1 Native and SDS polyaClylamide gel electrophoresis. 
Analytical electrophoresis was either performed on a PhastSystem (Pharmacia) 
using PhastGels (12.5% homogeneous or 8-25% gradient) or on a Mini Protean system II 
(Bio-Rad) lIsing Ready Gels (Bio-Rad). No additional sample preparations are needed for 
pelforming a native polyacrylamide gel electrophoresis (PAGE) on the PhastSystem, Prior 
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to performing a native PAGE on the Mini Protean system, the samples were mixed with 
20% glycerol (v/v) and 0.005% Bromophenol Blue (w/v). The settings for pelforming a 
native 12.5% homogeneous PAGE or a native 8 . 25% gradient PAGE with the PhastSy· 
stem are summarized below. When the Mini Protean system was used, the power supply 
was limited to 200 V and electrophoresis was tenninated as soon as the tracking dye 
(Bromophenol Blue) reached the bottom of the gel. 
Prior to performing a sodium dodecyl sulfate polyaclylamide gel electrophoresis 
(SDS·PAGE), the samples were mixed with an equal volume sample buffer (0.1 M Tris, 
0.04 M DTT, 0.14 M SDS, 20% glycerol (v/v), 0.005% Bromophenol Blue (w/v), pH 6.8) 
and boiled for 4 minutes. Subsequently the samples were applied on the gel. 
The seltings for performing a 12.5% SDS·PAGE with the PhastSystem are 
summarized below. The running conditions used for a SDS-PAGE on the Mini Protean 
system were similar as for a native PAGE (see above). 
Homogeneous 12.5% SDS PAGE 
Sample applicator down at x.2 OVh 
Sample applicator up at x.3 OVh 
Sep x.l 250V lO.OmA 3.0W 15"e IVh 
Sep x.2 250V l.OmA 3.0W 15°e IVh 
Sep x.3 250V lO.OmA 3.0W 15°e 70Vh 
Homogeneous 12.5% Native PAGE 
Sample applicator down at x.2 OVh 
Sample applicator up at x.2 2Vh 
Sep x.l 400V 1O.0mA 2.5W we lOVh 
Sep x.2 400V I.OmA 2.5W 15"e 2Vh 
Sep x.3 400V 1O.0mA 2.5W 15"e 120Vh 
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8 - 25% gradient Native PAGE 
Sample applicator down at x.2 OVh 
Sample applicator up at x.3 2Vh 
Sep x.1 400V lO.OmA 2.5W 15"e 10Vh 
Sep x.2 400V 1.0mA 2.5W 15"e 2Vh 
Sep x.3 400V lO.OmA 2.5W lye 268Vh 
2.7.2 Analytical isoelectric focusing 
Analytical isoelectric focusing was performed on a PhastSystem using PhastGel 
IEF (pH: 4 - 6.5). 
lsoelectric focusing on PhastGel pH 4 - 6.5 
Sample applicator down at x.2 OVh 
Sample applicator up at x.3 OVh 
Sep x.1 2000V 2.0mA 3.5W 15°e 485Vh 
Sep x.2 200V 2.0mA 3.5W 15"e 15Vh 
Sep x.3 2000V 5.0mA 3.5W 15"e 150Vh 
Sep x.4 200V 2.0mA 2.0W 15°e 500Vh 
For the determination of the micro heterogeneity of transferrin in serum samples 
(see chapter 6) a piece of Immobiline gel, ranging from pH 5 - 6, was cut out from an 
Immobiline gel (pH 4 - 7, Pharmacia) to the same size as a PhastGel. Prior to isoelectric 
focusing this gel was rehydrated for 90 minutes by applying I ml 20% (v/v) glycerol on 
the surface of the gel. Tf in the serum samples was saturated by adding 2 III 0.5 M 
NaHe03 and 2 ~I 10 mM Fe(III)-citrate to 50 ~I serum. 
After focusing the gel was incubated with 200 ).II rabbit anti-human Tf for 20 
minutes at room temperature. Subsequently the gel was washed in 0.15 M NaCI during 48 
hours before being stained. During this interval, the washing solution was changed several 
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times. After staining (see 2.7.3), the gels were quantitated with an Ultroscan XL 
densitometer (He/NeLaser, .l. ;::; 633 nm, Phannacia) connected to a personal computer 
with GelScan ™ XL software (version 2.1, Pharmacia). 
Isoelectric focusing on Immobiline pH 5 ~ 6 
Sample applicator down at x.2 OVh 
Sample applicator up at x.3 OVh 
Sep x.1 2000V l.5mA 1.5W 15°C 485Vh 
Sep x.2 200V O.3mA O.3W 15°C 15Vh 
Sep x.3 2000V 1.5mA 1.5W 15°C 1800Vh 
2.7.3 Staining of the gels. 
The gels were incubated with 20% TeA for 20 minutes prior to staining them with 
Coomassie Brilliant Blue R (I gIL) at 50°C for 10 minutes as described in the 
PhastSystem Users Manual (Pharmacia). Destaining was performed in 30% methanol (v/v), 
10% acetic acid (v/v) at room temperature. 
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Chapter 3 
3.1 Introduction 
In chapter 1 (1.5) specific variations in the oligosaccharide moieties of transferrin 
(Tt) in several (patho)physiological conditions such as pregnancy, rheumatoid arthritis, 
malignancies and alcohol abuse (1-10) were discussed. As stated, the significance of these 
variations as well as the function of the Tf glycans remain unclear. 
In the Carbohydrate Deficient Glycoprotein (CDG) syndrome, first reported by 
laeken et al. (11), strong deviations of the carbohydrate content of serum glycoproteins 
(e.g. transferrin) can be found. Even a subfraction of Tf completely lacking carbohydrates 
has been described (12,13). The consequence of these variations on the function of Tf 
remains unknown. Since the transferrins are not homogeneously affected, and all other 
glycoproteins are also affected, it is impossible to assign any of the clinical manifestations 
of the CDG syndrome merely to the Tf deviations. 
Recently, Hu et al. repOited (14) that in comparison to its fully glycosylated form, 
rat aglyco Tf showed a decreased iron donating capacity towards rat hepatocytes. This was 
not ascribed to a decreased affinity of the transferrin receptor (TfR) for the deglycosylated 
protein, but to a decreased interaction of aglyco Tf with "low-affinity binding sites" on the 
rat hepatocytes. His conclusions, however, were not based on binding experiments. The 
author also reported that no significant differences were found between rat aglyco Tf and 
rat Tf with respect to the affinity for iron, and with respect to the kinetics of the release of 
this metal from the N- and C-Iobe. 
Mason et al. (15) ran some experiments in a human cell test system. He reported 
that no difference could be found regarding receptor binding and iron donating capacities 
between human aglyco Tf (obtained by site-directed mutagenesis) and commercially 
available human Tf. However, as he conducted his experiments at 37°C, he unwillingly 
restricted himself to uptake studies. 
We decided to run proper binding experiments at 4°C to compare the affinity of 
normal human bi-bi Tf to 3 partially deglycosyJated subfractions and to human aglyco Tf. 
Subsequently we performed Tf and iron uptake studies at 3rc with bi-bi Tf, with the 3 
subfractions and with the human aglyco Tf. The experiments were run with the human 
hepatoma cell line PLC/PRF/5, otherwise known as the Alexander cell line. This cell line 
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was chosen because of the absence of the asialoglycoprotein receptor (16), in this way 
avoiding one of the difficulties of non TtR mediated binding and uptake. 
3.2 Materials and Methods 
3.2.1 Pm1ial deglycosylation of bi-bi-antennmy Tf 
In general we used human bi-bi Tf as a standard and as starting material for 
deglycosylation. Bi-bi Tf was prepared from commercially obtained human Tf by means 
of a Sepharose ConA column (see chapter 2). 
Partial deglycosylation was performed step-wise up to the mannose bifurcation (fig. 
1) by the proper exoglycosidases (neuraminidase, B-galactosidase and N-acetyl-B-D-
glucosaminidase), resulting in 3 partially deglycosylated Tf subfractions. In the following 
text the subfractions will be referred to as asialo Tf, agalacto Tf and aglucosamine Tf. 
Regarding aglucosamine Tf, please note that I mole aglucosamine Tf still contains 4 
moles of glucosamine in the chilobiose core. Attempts to deglycosylate aglucosamine Tf 
any further by alpha-mannosidase (Boehringer Mannheim) failed several times although 
conditions were varied. Removing Man3GlcNaci from aglucosamine Tf following the 
method described by Muramatsu (17) using endoglyeosidase D (Seikagaku, Tokyo, Japan) 
also failed for unknown reasons. 
Each enzymatical incubation step was followed by a purification of the incubated Tf as 
described in detail in 2.2.5. 
3.2.2 Isolation of aglyco Tf 
Aglyco Tf was obtained from a patient suffering from Carbohydrate Deficient 
Glycoprotein syndrome. It was isolated by means of Sepharose-bound anti-transferrin IgG 
affinity chromatography and preparative isoelectric focusing as described in 2.2.4. 
3.2.3 Carbohydrate analysis 
Carbohydrate analyses were performed on the purified Tf and on the aglyco Tf 
samples as described in 2.2.6. Complete lack of glycans on this isolated aglyco Tf was 
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demonstrated by carbohydrate analysis. 
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N-~cetyl-B-O-Glucosaminidase 
Figure 1. Biantennary glycan chain of the complex type showing the cleavage sites of the 
exoglycosidases used for partial deglycosylation. 
3.2.4 Electrophoresis and isoelectric focusing 
Sodium dodecyl sulphate polyaclylamide electrophoresis (SDS-PAGE) and 
isoeJectric focusing were perfonned as described in 2.7 on a PhastSystem (Pharmacia, 
LKB). 
3.2.5 Labeling of the transferrin subfraetions 
Radio-labeling with 1251 and 59Fe of bi-bi Tf, the 3 Tf subfractions and aglyco Tf 
was performed as described in 2.4. 
54 
Influence of Transferrin glycalls 011 receptor binding and iron donation 
3.2.6 Cell culturing conditions 
The human hepatoma cell line PLC/PRFI5 (European Collection of Animal Cell 
Cultures, Salisbury, U.K.) was cultured in cell culture flasks (Costar) at 37"C in 
humidified 5% C02/95% air. Details are described in 2.5.1. 
3.2.7 Binding studies 
Binding to hepatoma cells of 1251 labeled partially deglycosylated Tf subfractions 
was compared simultaneously in one experiment to the binding of 1251 labeled bi-bi Tf. 
Hepatoma cells were incubated (90 minutes, O°C) with 1251 labeled Tf in a concentration 
ranging from 0.25 Jlg to 3 flg per ml incubation medium. All binding experiments were 
run in duplicate. Nonspecific binding was determined in a parallel experiment by adding to 
the 1251 labeled Tf a 50 times excess of unlabeled Tf of the same subfraction as the type 
investigated. 
In a second experiment the binding of 1251 labeled aglyco Tf was compared to the 
binding of 1251 labeled bi-bi Tf. Unfortunately it was not possible to detennine nonspeci-
fic binding for the aglyco Tf in the presence of a 50 times excess of unlabeled aglyco Tf, 
because of its minute availability. Instead of an excess of unlabeled aglyco Tf, an excess 
of unlabeled bi-bi Tf was used. 
After incubation, the cells were washed, lysed and collected. Smface bound 
radioactivity was measured with a Packard 500C auto gamma spectrometer and the protein 
concentration of the different samples was determined according to the method described 
by Bradford (18). See for a more detailed description of the Tf binding assays chapter 2 
(2.5.2). 
3.2.8 Uptake studies 
Uptake studies were performed as described in detail in 2.5.3. Briefly, at t=O the 
hepatoma cells were incubated with 59Fe and 1251 labeled Tf in a concentration of 3 
~g/ml. At indicated times the incubation medium was removed and the celis were washed 
with icecold PBS. Surface bound Tf was removed by incubating the cells with acetate 
buffer (25 mM sodium acetate, 0.15 M NaCI, 20 mM CaCI2, pH 4.5, 4"C) for 8 minutes 
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followed by a 2 minute incubation in PBS (4°C). This procedure was repeated once. 
Subsequently the cells were lysed and collected. Intracellular 59pe and 1251 was 
determined with a Packard 500C autogamma spectrometer. As in the binding studies, the 
experimental results of the partially deglycosylated Tf subfractions were compared 
simultaneously to bi-bi Tf and the results of the aglyco Tf were compared to one of the 
transferrins, All experiments were run in duplicate. 
3,2,9 Mathematical analysis of the transferrin binding experiments 
A nonlinear curvefit program (Statgraphics, Statistical Graphics Corporation) was 
used to evaluate the data obtained in the binding assays according to the Langmuir 
equation for equilibrium binding: B = (Bmax *x)/(x+Kd) + nonspecific binding. B 
represents the fraction of Tf (subfraction) that is bound, Bmax is the saturation level for 
the specific binding, x is the concentration of the free Tf (subfraction) and Kd is the 
concentration of Tf (subfraction) at which the specific binding has reached half its 
maximum. The nonspecific binding is a linear function of x, 
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3.3 Results 
Pmtial deglycosylation results in a slight decrease in molecular mass, as can be 
seen on the SDS polyacrylamide gel shown in figure 2. Figure 3 shows that the isoelectric 
point (IEP) changes v 'len sialic acid is removed. Further deglycosylation has no influence 
on the IEP. 
105 
82 
49 
33.3 
28.6 
19.4 
2 4 5 
Figure 2. SDS PAGE (PhastGel Homogeneous 12.5) showing the different isotransferrin 
fractions. Lane I: fully glycosylated transferrin; lane 2: asialo transferrin; lane 3: agalacto 
transferrin; lane 4: aglucosamine transferrin; lane 5: aglycotransferrin. 
Markers are indicated in kDa. Staining was done with Coomassie Brilliant Blue R250. 
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pH 4 
Figure 3. IEF (PhastGel IEF 4 - 6.5) showing the different isotransferrin fractions. Lane I: 
fully glycosylated transfelTin; lane 2: asialo transfelTin; lane 3: agalacto transferrin; lane 4: 
aglucosamine transferrin; lane 5: aglycotransferrin. Staining was done with Coomassie 
Brilliant Blue R 250. 
Carbohydrate analysis data of the Tf subfractions and the isolated agJyco Tf are 
shown in table 1 and 2. Tabel 1 shows the almost total absence of galactose in agalacto Tf 
and the almost total absence of galactose and mannose in aglyco Tf. Table 2 depicts a 
decrease of 50% in the N-acetylglucosamine content of aglucosamine Tf and a nearly total 
absence of N-acetylglucosamine in aglyco Tf. 
As to the binding experiments; no significant difference as detelmined by a one 
way analysis of variance at p < 0.05 (Statgraphics, Statistical Graphics Corporation) could 
be revealed between the dissociation constants (Kd) of the investigated transfen·ins. The 
mean Kd was calculated at 4.2xI0-9 MIL (SD 3.lxI0-9 MIL). The transferrin binding 
curves are shown in figure 4. 
58 
Influence of Transferrin glycans on receptor binding and iron donation 
reference values agalacto aglycotransferrin 
serum transferrin transferrin 
Mannose 5.49 5.51 
Galactose 4.31 0.14 
Table 1. Galactose and man nose detelmination of agalacto 
aglycotransferrin. Rhamnose was used as an internal standard for the 
mannose and galactose in the aglycotransferrin fraction. 
0.52 
0.42 
transferrin and 
quantification of 
reference values aglucosamine aglycotransferrin 
serum transfen'in transferrin 
N-Acetyl glu- 8.0 4.1 0.8 
cosamine 
Threonine 30.0 29.8 30.7 
Serine 41.0 40.1 40.6 
Glutamate 59.0 57.9 60.0 
+NH2 
Glycine 50.0 50.3 48.8 
Alanine 57.0 49.4 57.3 
Valine 45.0 44.9 46.8 
Methionine 9.0 7.2 8.6 
Isoleucine 15.0 14.7 15.4 
Leucine 58.0 56.1 59.3 
Tyrosine 26.0 24.9 26.2 
Phenylalanine 28.0 27.3 28.4 
Aspartate 79.0 75.3 81.5 
+NH2 
Histidine 19.0 18.6 18.8 
Lysine 58.0 57.3 62.3 
Arginine 26.0 24.4 26.4 
Table 2. N-Acetylglucosamine detelmination of aglucosamine transferrin and aglyco-
transferrin. 
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The uptake of bi-bi Tf is compared to the partially deglycosylated Tf subfractions 
in fig. 5. The iron uptake from these transferrins is also compared in fig. 5. Regarding the 
Tf uptake, bi-bi Tf and the 3 partially deglycosylated Tf subfractions all reach a similar 
steady state in the hepatoma cells. The iron uptake rates from these transferrins by the 
hepatoma cells are also similar. In fig. 5 the results of one experiment being representative 
for all five experiments perfonned are shown. 
Fig. 6 depicts the results of an uptake experiment in which we compare bi-bi Tf 
with aglyco Tf. The steady state reached by the aglyco Tf is clearly lower than the steady 
state reached by bi-bi Tf. The iron donation rate by aglyco Tf is also distinctly lower 
compared to the iron donation rate by bi-bi Tf. 
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Figure 4. Total binding (.), specific binding (.) and nonspecific binding (0) of 1251 
labeled bi-bi transferrin, asialo transferrin, agalacto transferrin, aglucosamine transferrin 
and aglycotransferrin by PLC/PRF/5 cells. 
The total binding curve is fitted to the obtained data points using the function 
y=(Bmax *x)/(x+ Kd)+ nonspecific binding. 
The nonspecific binding for each Tf subfraction was determined by incubating the 
PLC/PRF/5 cells with the 1251 labeled Tf subfraction in the presence of a 50 times excess 
of the same (unlabeled) subfraction. Due to the minute availability of aglyco Tf, the 
nonspecific binding of this subfraction was determined using a 50 times excess of bi-bi Tf. 
The nonspecific binding curve was fitted to the obtained data points using the function 
y=a*x. 
The specific binding curve is calculated by subtracting the nonspecific binding from the 
total binding. In other words, the specific binding is represented by y=(B max *x)/(x+Kd ). 
The mean values of the obtained data points are given in the figures. 
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Figure 5. 125r_Tf and 59Fe uptake by PLC/PRF/5 cells. 
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Legend: +: fully glycosylated transferrin; ... : asialo transferrin; 0: agalacto transferrin; 
-: aglucosamine transferrin. 
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Figure 6. 125r. Tf and 59pe uptake by PLC/PRP/5 cells. 
Legend: +: fully glycosylated transferrin; .: aglycotransferrin. 
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3.4 Discussion 
In this chapter the effect of the Tf glycan chains on receptor binding and iron-
donating capacity of Tf is described. Fully glycosylated Tf was compared with partially 
deglycosylated Tf subfractions and aglyco Tf for the qualities mentioned above. 
Table 1 shows that agalacto Tf contains less than 5% of the galactose found in bi-
bi Tf. Aglucosamine Tf contains approximately 50% of the amount of N-acetyl glucosa-
mine found in bi-bi Tf, indicating that all distal N-acetyl glucosamine has been removed 
(Table 2). Only small amounts of sugar can be found in aglyco Tf (Table 1 and 2), 
approximately 10% of the normal values for all determined sugars. This can be easily 
explained by a slight contamination of the aglyco Tf with Tf bearing normal glycans. We 
therefore can conclude that the partial deglycosylation of the three transferrin subfractions 
has been successful and that the isolated aglyco Tf is deficient of carbohydrates. 
From our binding experiments we conclude that the oligosaccharides of Tf have no 
influence on the affinity of the TfR for its ligand. The calculated Kd values of the 
different binding experiments showed, unfortunately, from experimental run to run a high 
degree of variability (Table 3). This explains, when averaged, the high SD of the mean. 
The lack of oligosaccharides does not influence the iron binding of Tf as seen on 
an EPR spectrum (19). However the carbohydrates of Tf do affect the uptake of iron, and 
also the uptake of Tf itself by PLCIPRFI5 cells (fig. 6). 
Tf with oligosaccharides trimmed up to the mannose bifurcation has the same iron 
donating characteristics as its fully saturated counterpart, also the uptake of Tf itself 
remains unaffected (fig. 5). A similar uptake pattem of the partially deglycosylated Tf 
subfractions as bi-bi Tf (as shown in fig. 5), indicates that partially deglycosylated Tf is 
processed like normal Tf by the hepatoma cells. Regarding the uptake of aglyco Tf, this 
reaches a lower steady state than bi-bi Tf (fig. 6) or the Tf subfractions. Our results 
indicate that the lower part of the glycan chains i.e. up to and including the mannose 
bifurcation, is of importance for the uptake of both iron and Tf. 
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transferrin subfraction Krl 
bi-bi transferrin 11.5 
7.2 
2.3 
3.4 
asialo transferrin 4.2 
0.7 
4.2 
agalacto transferrin 5.5 
3.4 
7.0 
2.0 
aglucosamine transferrin 1.8 
9.9 
5.0 
aglycotransferrin 2.7 
0.5 
3.7 
0.7 
Table 3. The calculated Kd values for the different transferrin binding experiments. The 
values are given in 10-9 MIL. 
A reduced steady-state of aglyco Tf can be explained by a decreased endocytosis 
rate or by an increased exocytosis rate. The latter explanation is not velY likely, because 
the iron uptake of aglyco Tf is diminished compared to the partially and fully glycosylated 
transfelTins. 
The steady-state reached by the aglyco Tf also shows that this protein takes part in 
an endocytosis/exocytosis cycle, i.e. is not degraded in the cell. 
In summary, our experiments indicate that removing the oligosaccharides from Tf 
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does not influence the affinity of Tf for its receptor. Removing the 3 distal sugars from 
the Tf glycan chains does not alter the uptake of Tf (or iron) by PLC/PRFIS cells. 
However, a total lack of glycans on Tf reduces the uptake of this protein (and iron). 
Therefore the basal part of the Tf glycans seems to have an impoltant function in the 
endocytosis of the Tf-TfR complex. 
3.5 Summary 
Human bi-bi-antennary transferrin (bi-bi Tf) was partially deglycosylated 
enzymatically by step-wise incubation with one or more of the following exoglycosidases: 
neuraminidase, B-galactosidase or N-Acetyl-B-D-glucosaminidase. Aglyco Tf was isolated 
from serum of a patient suffering from the Carbohydrate Deficient Glycoprotein syndrome. 
Receptor binding and iron donating capacities of bi-bi Tf, of partially deglycosylated Tf 
subfractions and of aglyco Tf were compared using the human hepatoma cell line 
PLC/PRFIS. There was no difference in binding capacity between bi-bi Tf, the Tf sub-
fractions and aglyco Tf. The iron donating capacity of aglyco Tf, however, was signifi-
cantly reduced compared to bi-bi Tf and the other Tf subfractions. 
68 
lilfiuellce of Transferrin glycans 011 receptor binding and iron donation 
References 
1. Leger D., Campion B., Decottignies J-P., Montreuil J., Spik G. (1989) 
Physiological significance of the marked increased branching of the glycans of 
human serotransferrin during pregnancy. Biochem. 1., 257, pp 231-238. 
2 Van Eijk HG., van Noort W.L., de Jong G. and Koster J.F. (1987) Human serum 
sialo transferrins in diseases. Clin. Chim. Acta, 165, pp 141-145. 
3. de Jong G., van Dijk J.P., van Eijk H.G. (1990) The biology of transferrin. Clin. 
Chim. Acta, 190, pp 1-46. 
4. de Jong G., van Noort WL, Feelders R.A., de Jeu-Jaspars C.M.H., van Eijk HG. 
(1992) Adaptation of transferrin protein and glycan synthesis. Clin. Chim. Acta, 
212, pp 27-45. 
5 Stibler H., Allgulander C., Borg S., Kjellin K.G. (1978) Abnormal 
microheterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. 
Acta. Med. Scand., 204, pp 49-56. 
6 Yamashita K., Koide N., Endo T., lwaki Y. and Kobata A. (1989) Altered 
glycosylation of serum transferrin of patients with hepatocellular carcinoma. ]. 
BioI. Chern., 264, pp 2415-2423. 
7 Bierings M.B., Heeren J.W.A., van Noort WL, van Dijk J.P. and van Eijk H.G. 
(1987) Pregnancy and guinea-pig isotransferrins - isolation and characterization of 
both isotransferrins. Clin. Chim. Acta, 165, pp 205-211. 
8 Van Dijk J.P., van Noort WL, Kroos MJ., Starreveld J.S., and van Eijk H.G. 
(1991) Isotransferrins and pregnancy: a study in the guinea pig. Clin. Chim. Acta, 
203, pp 1-16. 
9 Rudolph J.R., Regoeczi E., Chindemi P.A., Southward S. (1987) In: Proc. 8th Int 
Conf on Proteins of Iron Transport and Storage. Montebello, Quebec. 
10 van Dijk J.P., van der Zande F.G.M., Kroos MJ., Starreveld I.S., and van Eijk 
H.G. (1993) Number and affinity of transferrin-receptors at the placental 
microvillous plasma membrane of the guinea pig: Influence of gestational age and 
degree of transferrin glycan chain complexity. I. Dev. PhysioI., 19, pp 221-226. 
11 laeken I., van Eijk H.G., van der Heul c., Corbeal L., Eeckels R., Eggermont E. 
(1984) Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly 
recognized genetic syndrome. Clin. Chim. Acta, 144, pp 245-247. 
69 
Chapter 3 
12 Yamashita K., Ohkura T., Ideo H., Ohno K., Kanai M. (1993) Electrospray 
ionization-mass spectrometric analysis of serum transferrin isofonns in patients 
with carbohydrate·deficient glycoprotein syndrome. J. Biochem., 114, pp 766-769. 
13 Yuasa I., Ohno K., Hashimoto K., Iijima K., Yamashita K., Takeshita K. (1995) 
Carbohydrate-deficient glycoprotein syndrome: electrophoretic study of multiple 
serum glycoproteins. Brain Dev., 17, pp 13-19. 
14 Hu W·L., Chindemi P.A., Regoeczi E. (1991) Reduced hepatic iron uptake from rat 
aglycotransferrin. BioI. Metals, 4, pp 90-94. 
15 Mason A.B., Miller K.M., Funk W.D., Banfield D.K., Savage K.J., Oliver R.W.A., 
Green B.N., MacGillivray R.T.A., Woodworth R.C. (1993) Expression of 
glycosylated and nonglycosylated human transferrin in mammalian cells. 
Characterization of the recombinant proteins with comparison to three 
commercially available transferrins. Biochemistry, 32, pp 5472-5479. 
16. Wu G.Y. and Wu C.H. (1986) Targeted inhibition of transferrin·mediated iron 
uptake in Hep G2 hepatoma cells. J. BioI. Chern., 261, pp 16834-16837. 
17 Muramatsu T., Koide N. and Maeyama K-1. (1978) Further studies on endo·B·N· 
acetylglucosaminidase D. J. Biochem., 83, pp 363-370. 
18 Bradford M.M. (1976) A rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein-dye binding. Ana1. 
Biochem., 72, pp 248-254. 
19 Hoefkens P., de Smit M.H., de Jeu·Jaspars N.M.H., Huijskes·Heins M.I.E., de Jong 
G. and van Eijk H.G. (1996) The isolation, renaturation and partial characterization 
of recombinant human transferrin and its half-molecules from Escherichia coli. Int. 
J. Biochem. Cell BioI., in press. 
70 
Renaturation of recombinant 
human transferrin and its half-
molecules 
Chapter 4 
4.1 Introduction 
The growing interest in the function of oligosaccharides of glycoproteins has led to 
an increasing amount of studies in this field. Transferrin (Tf) does not constitute an 
exception and numerous studies have been published regarding this protein in relation to 
its glycan chains. 
Nowadays a lot of data are available, specifically on the variations in the Tf gly-
cans during certain diseases like hepatocellular carcinoma, rheumatoid arthritis and 
Parkinson's disease (1-5), as well as on changes that occur during pregnancy (6-11). 
Characteristic changes in the glycan moieties of Tf are also reported to occur in excessive 
alcohol intake (12.38, see also chapter 6). 
Although subject to speculation, the physiological significance of these variations 
in the glycan composition remains unknown, but several facts are already ascertained. For 
instance, the Tf glycans do not influence the intracellular transport of the protein during 
synthesis (13-16), a well known function of glycans of several other glycoproteins. 
Another reputed fact is, that glycosylation does not influence the affinity of Tf for iron or 
for the transferrin receptor (TfR), but lack of the glycan chains reduces the iron donation 
of Tf to hepatocytes (17,18,19). 
Studying the biochemical, structural and physiological propelties of human Tf 
lacking the glycans could give more insight in the function of the glycans. To run 
experiments it is necessary to obtain fair amounts of aglyco Tf. As discussed in chapter 1 
(section 1.6), there are several options for producing aglyco Tf: removing the glycans of 
Tf either chemically or enzymatically, inhibition of glycosyJation of de novo synthesized 
Tf, producing nonglycosylated Tf in eukaryotic cells using site-directed mutagenesis or 
finally, producing Tf in organisms unable to glycosylate proteins (e.g. Escherichia coli). 
For producing high quantities of aglyco Tf the latter method seems to be the most prefera-
ble (see chapter 1). 
Although the high productivity of and the low culture requirements for E. coli are 
of advantage, the accumulation of the overexprcssed proteins as insoluble protein 
aggregates (better known as inclusion bodies) is a major drawback. As discussed in 
chapter 1, recombinant proteins can be refolded after solubilizing the inclusion bodies 
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(20,21,22), This is an absolute requirement in studying the biochemical properties of the 
produced recombinant proteins. 
The bacterial expression system as described by us (23) has been employed as 
source for aglyco recombinant human transferrin (rhTf) as well as C-terminal (rhTfI2C) 
and N-telminal (rhTfI2N) half-transferrins, 
In this chapter the isolation, renaturation and partial characterization of rhTf, 
rhTfl2N and rhTfl2C from E. coli cultures expressing these proteins is described. 
Following purification the amino acid compositions of these recombinant proteins were 
determined in order to compare these compositions with the theoretical one which is 
known from the primary structure. In addition the first 10 - ]5 amino acids from the N-
terminal side of the three recombinant products were sequenced. The recombinant 
transferrins were refolded into water soluble proteins and subsequently their iron-binding 
capacity was determined. 
4,2 Materials and Methods 
4.2.1 RhTf, rhTf/2N and rhTfl2C production in E. coli 
Production of rhTf and the recombinant half-molecules in E. coli was performed as 
described by us (23, see also 2,3,1), 
4.2.2 Pur~tlcation of rhTf, rhTf/2N and rhTf/2C 
The cultured bacteria were harvested using a MSE Coolspin centrifuge at 2600 g 
for 15 minutes. The cells were resuspended in 10 m! 50 mM Tris/HC1, 1 mM EDTA, 250 
mM NaCl, 5 mM DTT, pH 8.0 and disrupted by adding approximately 100,000 U lysozy-
me. After incubating for 30 minutes at room temperature the sample was snap-frozen by 
submersing it in a mixture of solid CO2 and ethanol. The thawed sample was sonicated. 
Approximately 300 U DNase I was added and the sample was incubated for 45 minutes at 
room temperature. 
We isolated the inclusion bodies from this cell lysate by centrifugation at 12,000 g 
for 15 minutes. The pellet, containing the inclusion bodies, was washed 3 times with 50 
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mM Tris/HCI, I mM DTT, pH 8.0 and dissolved in 10 ml 8 M urea, I mM DTT, 40 mM 
Tris/HCI, 10% glycerol (v/v), pH 7.6. 
We used preparative SDS electrophoresis to purify rhTf, rhTf/2N and rhTfI2C. This 
was performed with a model 392 Bio-Rad Prep Cell. We mixed 600 ~I of rhTf, rhTf!2N 
or rhTf!2C solution with an equal volume of 8% SDS (w/v), 24% glycerol (v/v), SO mM 
Tris/HCI, 4% B-mercaptoethanol (v/v), 0.01 % Serva blue G (w/v), pH 6.8 and we 
incubated for 30 minutes at 40°C. This sample was applied to run on the polyaclylamide 
gel (9% T, 3.3% C) of the Prep Cell. The separated proteins were eluted from the gel at 
very low concentrations. Due to these very low concentrations the isolated proteins were 
very difficult to distinguish on the chromatogram. Therefore the collected fractions were 
concentrated using Centriflo CF 25 cones (Amicon) and run on analytical 9% SDS 
polyaclylamide gels. The fractions containing the pure recombinant Tf were collected. 
4.2.3 Amino acid analysis 
The recombinant proteins were analysed using an Alpha Plus 4151 amino acid 
analyser (Pharmacia LKB Biochrom Ltd., Cambridge, England). The proteins were 
hydrolysed first by mixing SO ~I (0.5 - 1.0 gIL) protein solution with ISO ~I 4 M Para-
toluene sulfonic acid and 2% 3-(2-amino ethyl) indole HCI (24). This mixture was left far 
24 hours at 110°C. After hydrolysis the mixture was titrated with I M NaOH to pH 2.0, 
and 0.2 M lithium citrate was added to a final volume of 2 mL We analyzed a sample of 
this mixture. During the analysis the eluent was mixed with a 0.2% (w/v) ortho-phthal 
aldehyde (O.P.A.) reagent in 1 M borate. The signal was measured with a fluorimeter F 
] 000 (Merck Hitachi, Amsterdam). As a reference we used a very pure human Tf 
preparation (4 sialo-bibi-antennary Tf of the genetic C1 type) isolated as described in van 
Noart ef al. (25). 
For protein sequencing a model 473A Protein Sequencer (Applied Biosystems) was 
used, performing Edman degradation and phenylthiohydantoin amino acid analysis. 
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4.2.4 Renaturatian of rhTf, rhTf/2C and I11Tf!2N 
Renaturation experiments were perfonned with the inclusion body solution without 
fmther purification of the recombinant proteins. Prior to renaturation the protein 
concentration of the inclusion body solution was detennined according to the method of 
Bradford (26). Renaturation was perfonned by diluting the proteins in a renaturation buffer 
(0.1 mM Na-EDTA, 0.1 mM Tris/HCI, 1.0 mM GSH, pH 8.2, 6°C) to a concentration of 
20 ~g/ml. This mixture was left for 15 minutes. Subsequently GSSG was added to a final 
concentration of 0.5 mM. This solution was left for another 22 hours at 6°e. Renaturation 
buffer was thoroughly degassed prior to use and renaturation was performed under an 
atmosphere of nitrogen. After renaturation the solution was concentrated and dialysed 
against 10 mM NaHC03 using an UItrasette with an omega 10 kDa membrane (Filtron). 
Subsequently the solution was filtered and concentrated using first an Amicon Stirred Cell 
with a PM 10 membrane, and finally Centriflo cones, CF 25 (Amicon). Af~er this 
concentration step the acquired proteins (rhTf, rhTfl2C or rhTfl2N) were separated from 
the other proteins by a Sepharose-bound anti-transferrin column (27). Finally the purified 
recombinant transferrins were saturated with iron using a FeCl3INT A solution, hoping in 
this way to stabilize our product. 
To determine whether the recombinant transferrins bind iron, rhTf, rhTfl2C and 
rhTfI2N were saturated with radio labeled iron using a 59FeCI3/NTA solution (59FeCI3' 
Amersham Life Science) following standard procedures as described in 2.4. The different 
recombinant transferrin samples saturated with 59Fe were loaded onto two 12.5% homoge-
neous polyacrylamide PhastGels (Pharmacia). One gel was used to illuminate an X-ray 
film and the other gel was stained for proteins using Coomassie Brilliant Blue R-250. We 
also detennined the molecular weight of the proteins in the different samples by running 
them on a 12.5% homogeneous SDS polyacrylamide gel. 
4.2.5 Spectrophotometry and EPR 
Absorption spectra and A280/465 ratios of the iron saturated recombinant 
transferrins were determined using an Ultrospec III spectrophotometer provided with the 
appropriate software (Pharrnacia, LKB). 
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EPR spectra were determined using a Bruker EPR 200 D spectrometer as described 
by Pierik and Hagen (28). 
4.3 Results 
The rhTf, rhTfI2C and rhTfI2N samples purified from inclusion bodies by means of 
preparative SDS electrophoresis each showed one protein band on a 9% SDS-
polyacrylamide gel (fig. I). As expected, rhTf migrated slightly faster than human Tf. The 
lack of oligosaccharide chains reduces the Mw by approximately 4 kDa. RhTfI2N and 
rhTf/2C showed bands just above the 32.5 kDa marker, which corresponds with the 
calculated Mw of respectively 37.3 kDa and 38.3 kDa. 
In table 1 the amino acid composition of rhTf, rhTf/2N and rhTfI2C is compared to 
that of human Tf. The composition of the recombinant transferrins corresponds very well 
with the composition of human Tf. Most amino acids show less then 5% deviation from 
the expected values. In table 2 the sequence of the first 10 - 15 amino acids from the N-
terminal side of the 3 recombinant proteins is compared to the sequence of the amino 
acids as determined for Tf (29). These sequences match the references exactly except for 
one N-terminal extra methionine in each recombinant protein and a glutamic acid replace-
ment by glutamine in rhTfl2C. The latter was introduced during construction of the 
expression-plasmid and wiIl be discussed later on. 
An absorption spectrum of the iron saturated recombinant transferrins was 
determined in the range from 280 nm to 600 nm. Normal diferric human Tf has an 
absorption maximum at 465 nm. The recombinant transferrins showed spectra similar to 
that of diferric human Tf with an absorption maximum at 462 nm, 459 nm and 464 om for 
rhTf, rhTf/2C and rhTfI2N respectively. Normal diferric Tf has an A280/465 ratio equiva-
lent to 21, this value has also been reported for iron-saturated human Tfl2N (30). For rhTf, 
rhT1I2C and rhTfl2N we calculated values of 30, 28 and 24. Assuming these ratios can be 
converted into iron-saturation values as can be done with normal Tf, these figures 
correspond with 70% and 90% iron-saturation for IhTf and rhTf/2N respectively. 
Assuming the A280/465 ratio for iron-saturated human Tf/2C is equal to that of human Tf 
and human Tfl2N the calculated value for rhTfl2C corresponds with 75% iron-saturation. 
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2 3 4 5 6 7 
Figure 1: SDS-Page (9%) showing the purified recombinant proteins and the solubilized 
inclusion bodies from which these proteins were isolated. 
Lane I: Tf; lane 2: rhTf; lane 3: inclusion body solution containing rhTf; lane 4: rhTf/2N; 
lane 5: inclusion body solution containing rhTfl2N; lane 6: rhTfl2C; lane 7: inclusion body 
solution containing rhTfl2C. 
Markers are indicated in kDa. Staining was done with Coornassie Brilliant Blue 0250. 
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recombinant reference N-terminal reference C-terminal reference 
human values half-trans- values N- half-trans- values C-
transferrin serum ferrin (rhTf- terminal ferrin (rhTf- terminal 
(rhTf) transferrin I2N) part of 12C) part of 
serum serum 
transferrin transferrin 
Lysine 53.7 58 25.9 27 26.9 31 
Histidine 18.0 19 9.2 9 8.7 10 
Arginine 24.9 26 10.6 12 14.7 14 
Aspartate 74.0 79 35.3 36 42.2 43 
+NH2 
Threonine 30.2 30 12.9 13 16.3 17 
Serine 40.4 41 20.2 21 20.6 20 
Glutamate 57.8 59 28.5 29 32.4 30 
+NH2 
Proline n.d. 32 n.d. 20 n.d. 12 
Glycine 51.5 50 25.2 24 27.3 26 
Alanine 58.4 57 31.7 32 25.3 25 
Cysteine n.d. 38 n.d. 16 n.d. 22 
Valine 44.7 45 22.7 22 22.3 23 
Methionine 9.4 9 5.8 5 5.3 4 
Isoleucine 14.6 15 7.8 8 7.6 7 
Leucine 55.2 59 30.7 29 29.5 30 
Tyrosine 26.0 26 15.2 14 12.0 12 
Phenyla- 25.8 28 15.4 16 13.1 12 
lanine 
Tryptophan 7.5 8 2.9 3 4.2 5 
Total 679 336 343 
Total 592.1 609 300 300 308.4 309 
minus Cys 
and minus 
Pro 
deviation 3.6 3.3 5.5 
from % % % 
predicted 
values 
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Table 1. Amino acid analysis of recombinant transferrins (mol amino acid/mol protein). 
Sums of Asparagine and Aspartate and sums of Glutamine and Glutamate are given 
because of interconversion of these amino acids in the hydrolysis procedure. 
The colour reactant used in the analysis procedure yields low absorbance products for 
Proline and Cysteine and are therefore not determined (N.D.). 
The deviation represents the cumulated difference between detennined numbers of separate 
amino acids in the transfelTin species compar~d to the reference values derived from 
figures based on the transferrin characterization by Yang et al. (29). 
serum Tf rhTf rhTfI2N serum Tf rhTfI2C 
Met Met Met 
01 Val Val Val 337 Asp Asp 
02 Pro Pro Pro 338 Glu Gin 
03 Asp Asp Asp 339 Cys Cys 
04 Lys Lys Lys 340 Lys Lys 
05 Thr Thr Thr 341 Pro Pro 
06 Val Val Val 342 Val Val 
07 Arg Arg Arg 343 Lys Lys 
08 Trp Trp Trp 344 Trp Trp 
09 Cys Cys Cys 345 Cys Cys 
10 Ala Ala Ala 346 Ala Ala 
II Val Val Val 347 Leu Leu 
12 Ser Ser Ser 
13 Glu Glu Glu 
14 His His His 
Table 2. Amino acid sequence of the recombinant transferrins, sequenced from the N-
terminus, compared with the expected sequence according to Yang et al. (29). 
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The renatured recombinant transferrins were saturated with 59pe using a 
59FeCl3INTA solution. This sample was run on a native polyacrylamide gel (fig. 2A). The 
59pe saturated recombinant proteins all show more than one band on the autoradiograph 
(fig. 2B). The difference in migration pattern between rhTfI2C and rhTfI2N on the 
autoradiograph and the native polyacrylamide gel is remarkable. This difference is not 
secn on the SDS polyaclylamide gel (fig. 3). 
The EPR spectra of the recombinant transferrins are nearly identical with the 
spectrum of native Tf (fig. 4). 
The final efficiency of the renaturation experiments are estimated at approximately 
5% based on the measured absorption at 465 nm of the renatured and with iron saturated 
recombinant transferrins . 
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2 3 4 
Figure 2A. Native PAGE (12.5%) showing the renatured recombinant proteins. 
Lane I: Tf (Behringwerke); lane 2: rhTf; lane 3: rhTfI2C; lane 4: rhTf/2N. 
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2 3 4 
Figure 2B. Autoradiograph of a comparable gel as shown in figure 2A. 
Only the recombinant proteins were saturated with 59pe. 
Lane 2: rhTf; lane 3: rhTf12C; lane 4: rhTfI2N. 
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............................... ~ 
Figure 3. SDS PAGE (12.5%) showing the renatured recombinant proteins. 
Lane I: Tf (Behringwerke); lane 2: rhTf; lane 3: rhTfl2C; lane 4: rhTfI2N. 
Markers are indicated in kDa. Staining was done with Coomassie Brilliant Blue R250. 
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B 
A 
B 
."""" C 
0 
45 70 95 mT 105 155 
Fig. 4. Comparison of the EPR spectra of Tf and the recombinant transferrins. 
A: Tf; B: rhTf; C: rhTf!2N; D: rhTfI2C. 
EPR conditions: 
A 
B 
C 
0 
205 mT 
Fig. 4A: microwave frequency: 9315 MHz; microwave power: 80 mW; modulation 
amplitude: 0.8 mT; temperature: 9 K. 
Fig. 4B: microwave frequency: 9315 MHz; microwave power: 0.8 mW; modulation 
amplitude: 0.5 mT; temperature: 9 K. 
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4.4 Discussion 
Several authors have reported the production of recombinant Tf in E. coli (36,37). 
Hershberger et 01. (36) also repOlted on renaturation of recombinant Tf, although no data 
were shown. 
In this chapter we report on the purification and renaturation of rhTf, rhTfl2C and 
rhTf2/N (39), produced in E. coli as described by us (23). We reported the production of 
the different recombinant transferrins amounts up to 60 mglL cell culture. Our renaturation 
procedure has a final efficiency of approximately 5%. This estimation is based on the 
measured absorption at 465 nm of renatured and with iron saturated recombinant 
transferrin and on the assumption that only correctly folded recombinant transferrin binds 
iron. The measured absorption at 465 nm is indicative for the iron content of the renatured 
transferrins. 
After purification the amino acid composition of rhTf, rhTfI2C and rhTf!2N were 
determined. Their compositions match very well the one to be expected from human Tf. 
This does not only prove that our samples contain the proteins of our interest, but also 
confinns that they are very pure. 
N -tenninal sequencing shows that the recombinant transferrins all have an extra 
methionine at the N-tenninus (table 2). The difference in the amino acid sequence of 
rhTfl2C (amino acid 338) is due to the introduction of a KpnI-site in the Tf cDNA (23). 
Apart from this, the amino acid sequences of the recombinant transferrins match the 
expected sequences exactly (29). 
In our first renaturation experiments we used reduced Tf, that was denatured by 
SDS and urea. Attempts to renature Tf after such a treatment all failed. Although total 
removal of SDS from proteins has been reported (31,32,33), we were not able to remove 
this detergent from denatured Tf without complete precipitation of our protein of interest. 
Hence, renaturation experiments were performed with our inclusion body solution 
following a procedure derived from Hirose (34,35). We adapted this method to our 
experimental system; i.e. we abandoned prior isolation of the recombinant proteins by 
means of preparative SDS electrophoresis. 
After our renaturation and purification procedure the recombinant transferrins all 
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show a few bands on a native polyacrylamide gel (fig 2A). This phenomenon can not be 
caused by differences in molecular weight, because the same samples all show one single 
band on a SDS gel (fig.3), except for a weak second band in lane 2, corresponding with 
the position of half-transferrin. The generation of half-molecules of rhTf can easily be 
explained to be the result of proteolytic activity of E. coli enzymes. 
An explanation for the appearence of more than one band on the native gel could 
be that they represent different conformations of the protein, for example due to variations 
in disulphide bond formation. These confOlmational differences could affect the iron-
binding sites, resulting in a decreased iron saturation as shown in our results. 
On the native 12.5% homogeneous polyacylamide gel one of the major rhTf12C 
bands was positioned approximately at the same level as the rhTf bands (Fig. 2A). On the 
other hand, on a gradient polyacrylamide gel (PhastGel 8-25%) this band was found more 
at the level of the rhTfI2N bands (resuits not shown). Regarding these two findings it 
seems most unlikely that this band represents a dimer of rhTf/2C. Moreover, dimerization 
as a result of intermolecular disulphide bridge formation was excluded, since none of the 
recombinant proteins showed any extra bands on a 12.5% homogeneous polyacrylamide 
SDS gel run under non-reducing conditions compared to a SDS gel run under reducing 
conditions (results not shown). 
The recombinant transferrins are all capable of binding iron as shown on the 
autoradiograph (fig. 2B). This capability is also indicated by the similarity of the different 
recombinant transferrins absorption spectra and the spectrum of iron saturated Tf. AlI 
spectra have an absorption maximum near 465nm. 
Moreover, the EPR spectra of the recombinant proteins are nearly identical with the 
EPR spectrum of human Tf. Thus the iron atoms in the recombinant proteins and in the 
native Tf are bound in a similar way. This strongly suggests that the iron-binding sites of 
the recombinant transferrins are intact. The minor differences seen in the EPR spectra are 
possibly a result of differences between the transferrins, e.g. presence or absence of 
oligosaccharides. 
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4.5 Summary 
Recombinant human transferrin as wen as N- and C-terminal half-transferrins, 
produced in Escherichia coli are deposited in inclusion bodies by the bacteria. The 
isolation and purification of the recombinant proteins from these inclusion bodies are 
described in this chapter. 
The amino acid compositions and N-terminal sequences of the proteins were 
determined, and found to be in agreement with the known protein structure of human 
serum Tf. Renaturation of the recombinant proteins is described, resulting in water soluble 
iron-binding molecules. Iron binding was confiImed by 59pe labeling, absorption 
spectrophotometry and EPR spectrometry. 
87 
Chapter 4 
References 
Yamashita K., Koide N., Endo T., Iwaki Y. and Kobata A. (1989) Altered 
glycosylation of serum transferrin of patients with hepatocellular carcinoma. J. 
BioI. Chern., 264, pp 2415-2423. 
2 Matsumoto K., Maeda Y., Kato S. and Yuki H. (1994) Alteration of asparagine-
linked glycosylation in serum transferrin of patients with hepatocellular carcinoma. 
Clin. Chim. Acta, 224, pp 1-8. 
3 Campion B., Leger D., Wieruszeski J-M., Montreuil J. and Spik G. (1989) Presence 
of fucosylated triantennary, tetraantennary and pentaantennary glycans in transferrin 
synthesized by the human hepatocarciooma cell line Hep G2. Eur. 1. Biochem., 
184, pp 405-413. 
4 Fee1ders R.A., Vreugdenhil G., de Jong G., Swaak AJ.G. and van Eijk H.G. (1992) 
Transferrin micro heterogeneity in rheumatoid arthritis. Relation with disease 
activity and anemia of chronic disease. Rheumatol. Int., 12, pp 195-199. 
5 van Kamp GJ., Mulder K., Kuiper M. and Wolters E. Ch. (1995) Changed 
transferrin sialylation in Parkinson's disease. Clio. Chim. Acta, 235, pp 159-167. 
6 Leger D., Campion B., Decottignies J-P., Montreuil J., Spik G. (1989) 
Physiological significance of the marked increased branching of the glycans of 
human serotransferrin during pregnancy. Biochem. J., 257, pp 231-238. 
7 Bierings M.B., Heeren J.W.A., van Noort W.L., van Dijk J.P. and van Eijk H.G. 
(1987) Pregnancy and guinea-pig isotransferrins - isolation and characterization of 
both isolransferrins. Clin. Chim. Acta, 165, pp 205-211. 
8 van Dijk J.P., van Noort W.L., Kroos MJ., Starreveld J.S. and van Eijk H.G. 
(1991) Isotransferrins and pregnancy: a study in the guinea pig. Clin. Chim. Acta, 
203, pp 1-16. 
9 de Jong G., van Noort W.L., Feelders R.A., de Jeu-Jaspars C.M.H., van Eijk H.G. 
(1992) Adaptation of transferrin protein and glycan synthesis. Clio. Chim. Acta, 
212, pp 27-45. 
10 van Dijk J.P., van der Zande F.G.M., Kroos MJ., Starreveld J.S. and van Eijk H.G. 
(1993) Number and affinity of transferrin-receptors at the placental microvillous 
plasma membrane of the guinea pig: Influence of gestational age and degree of 
transferrin glycan chain complexity. J. Dev. Physiol., 19, pp 221-226. 
II de Jong G., Fee1ders R.A., van Noort W.L. and van Eijk H.G. (1995) Transferrin 
microheterogeneity as a probe in normal and disease states. Glycoconjugate 
88 
Renaturation of recombinant human transferrin and its half-molecules 
10urnal, 12, pp 219-226. 
12 Stibler H., Allgulander c., Borg S., Kjellin K.G. (1978) Abnormal 
microheterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. 
Acta. Med. Scand., 204, pp 49-56. 
13 Bell-Quint 1., Forte T. and Graham P. (1981) Glycosylation of apolipoproteins by 
cultured rat hepatocytes. Biochem. 1., 200, pp 409-414. 
14 Yeoh G.C., Vogel P., Daly 1., Brighton V.J., Light A. and Petterson D.S. (1984) 
Effect of corynetoxin isolated from parasitized annual ryegrass on albumin and 
transferrin synthesis and secretion by cultured fetal rat hepatocytes. Exp. Cell Res., 
151, pp 421-432. 
15 Bauer H.C., Parent 1.B., Olden K. (1985) Role of carbohydrate in glycoprotein 
secretion by human hepatoma cells. Biochem. Biophys. Res, Commun., 128, pp 
368-375. 
16 Katz N.R., Goldfarb V., Liem H. and Muller-Eberhard U. (1985) Synthesis and 
secretion of hemopexin in primary cultures of rat hepatocytes, Demonstration of an 
intracellular precursor of hemopexin. Eur. 1. Biochem., 146, pp 155-159. 
17 Hu W-L., Chindemi P.A. and Regoeczi E. (1991) Reduced hepatic iron uptake 
from rat aglycotransferrin. BioI. Metals, 4, pp 90-94. 
18 Mason A.B., Miller K.M., Funk W.D., Banfield D.K., Savage K.J., Oliver R.W.A., 
Green B.N., MacGillivray R.T.A., Woodworth R.C. (1993) Expression of 
glycosylated and nonglycosylated human transferrin in mammalian cells. 
Characterization of the recombinant proteins with comparison to three 
commercially available transferrins. Biochemistry, 32, pp 5472-5479. 
19 Hoefkens P., Huijskes-Heins M.I.E., de leu-laspars C.M.H., van Noort WL and 
van Eijk H,G. (1996) Influence of transferrin glycans on receptor binding and iron 
donation. Glycoconjugate Journal, in press. 
20 Buchner J, and Rudolph R. (1991) Routes to active proteins from transformed 
micro-organsisms. Current Opinion in Biotechnology, 2, pp 532-538. 
21 Schein C.H. (1991) Optimizing protein folding to the native state in bacteria. 
Current Opinion in Biotechnology, 2, pp 746-750. 
22 Kelley R.F. and Winkler M.E. (1990) Folding of eukaryotic proteins produced in 
Escherichia coli. In: Genetic Engineering, Vol. 12. (Ed. 1.K. Setlow) pp 1-19, 
Plenum Press, New York. 
89 
Chapter 4 
23 de Smit M.H., Hoefkens P., de Jong G., van Duin J., van Knippenberg P.H., van 
Eijk H.G. (1995) Optimized bacterial production of nonglycosylated human 
transferrin and its half-molecules. Int. J. Biochem. Cell BioI., 27, pp 839-850. 
24 van Eijk H.G. and van Noort W.L. (1986) The reliability of the use of para toluene 
sulfonic acid for simultaneous hydrolysis and quantitation of both N-acetyl-
glucosamine and amino acids in human transferrins. Clin. Chim. Acta, 157, pp 305-
310. 
25 van Noort W.L., de Jong G., and van Eijk H.G. (1994) Purification of 
Isotransferrins by Concanavalin A Sepharose Chromatography and Preparative 
Isoelectric Focussing. Eur. J. Clin. Chem. Clin. Biochem., 32, pp 885-892. 
26 Bradford M.M. (1976) A rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein-dye binding. AnaL 
Biochem., 72, pp 248-254. 
27 van Eijk H.G. and van Noort W.L. (1976) Isolation of rat transferrin using CNBr-
activated sepharose 4 B. J. Clin. Chem. Biochem., 14, pp 475-478. 
28 Pierik AJ. and Hagen W.R. (1990) S = 9/2 EPR signals are evidence against 
coupling between the siroheme and the PelS cluster prosthetic groups in 
Desulfovibrio vulgaris (Hilden borough) dissimilatory sulfite reductase. Eur. J. 
Biochem., 195, pp 505-516. 
29 Yang F., Lum J.B., McGill J.R., Moore C.M., Naylor S.L. van Bragt P.H., Baldwin 
W.D., Bowman B.H. (1984) Human transferrin: cDNA characterization and 
chromosomal localization. Proc. Natl. Acad. Sci. USA., 81, pp 2752-2756. 
30 Funk W.D., MacGillivray R.T.A., Mason A.B., Brown S.A., Woodworth R.C. 
(1990) Expression of the amino-tenninal half-molecule of human serum transferrin 
in cultured cells and characterization of the recombinant protein. Biochemistry, 29, 
pp 1654-1660. 
31 Kapp O.H. and Vinogradov S.N. (1978) Removal of sodium dodecyl sulfate from 
proteins. Anal. Biochem., 91, pp 230-235. 
32 Hager D.A. and Burgess R.R. (1980) Elution of proteins from sodium dodecyl 
sulfate, and renaturation of enzymatic activity: results with sigma subunit of 
Escherichia coli RNA polymerase, wheat germ DNA topoisomerase, and other 
enzymes. Anal. Biochem., 109, pp 76-86. 
33 Suzuki H. and Terada T. (1988) Removal of dodecyl sulfate from protein solution. 
Anal. Biochem., 172, pp 259-263. 
90 
Renaturation of recombinant human transferrin and its half-molecules 
34 Hirose M., Akuta T., Takahashi N. (1989) Renaturation of ovotransferrin under 
two-step conditions allowing primary folding of the fully reduced fonn and the 
subsequent regeneration of the intramolecular disulfides. 1. BioI. Chern., 264, pp 
16867 -16872. 
35 Hirose M. and Yamashita H. (1991) Partially folded state of the disulfide-reduced 
N-tenninal half-molecule of ovotransferrin as a renaturation intermediate. J. BioI. 
Chern., 266, pp 1463-1468. 
36 Hershberger C.L., Larson J.L., Arnold B., Rosteck Jr P.R., Williams P., DeHoff B., 
Dunn P., O'Neal K.L., Riemen M.W., Tice P.A., Crofts R., Ivancic J. (1991) A 
cloned gene for human transferrin. Ann. N.Y. Acad. Sci., 646, pp 140-154. 
37 Steinlein L.M. and Ikeda R.A. (1993) Production of N-telminal and C-terminal 
human serum transferrin in Escherichia coli. Enzyme Microb. Technol., 15, pp 193-
199. 
38 Hoefkens P., Higgins L., Ward R.J. and van Eijk H.G. (1996) Evaluation of 
Carbohydrate-deficient transferrin as a marker of alcohol abuse. Alcohol. Alcohol, 
in press. 
39 Hoefkens P., de Smit M.H., de Jeu-Jaspars N.M.H., Huijskes-Heins M.I.E., de Jong 
G., van Eijk H.G. (1996) The isolation, renaturation and partial characterization of 
recombinant human transferrin and its half-molecules from Escherichia coli. Int. 1. 
Biochem. Cell Biol., in press. 
91 

Receptor binding and iron 
donation by the recombinant 
transferrins 
Chapter 5 
5.1 Introduction 
In this chapter the biological activity of refolded recombinant transferrin (rhTf), 
recombinant C-terminal half-transferrin (rhTf/2C) and N-terminal half-transferrin (rhTfI2N) 
was studied, Transferrin binding and iron uptake of these proteins were detennined. 
As shown in the preceeding chapter recombinant transferrin and both its half-
molecules isolated from inclusion bodies, can be renatured in a water soluble form capable 
of binding iron, The iron binding capacities of both rhTf and rhTf12C compared to Tf 
were estimated at approximately 70% on the basis of measured A280/465 ratios. For 
rhTfI2N this value was estimated to be 90% (I). 
The inability to saturate our recombinant proteins totally with iron suggests that not 
all the proteins are refolded into their native conformation. Nevertheless it can be very 
interesting to detennine the receptor binding and iron-donating ability of the refolded 
proteins, 
5.2 Materials and Methods 
5.2.1 Cell culture 
For the uptake and binding experiments PLCIPRF/5 cells were used. This human 
hepatoma cell line was obtained from the European Collection of Animal Cell Cultures 
(Salisbury, U.K.). Cells were cultured as described in detail in 2.5.1. 
5.2.2 Labeling of the transferrins 
Labeling of the 3 recombinant transferrins and bi-bi antennary Tf (bi-bi Tf) with 
1251 and 59Fe was performed as described in detail in 2.4. Regarding the labeling with 
59Fe, this procedure was slightly adjusted for both recombinant half-transferrins. A half Tf 
molecule only binds one iron atom, so recombinant half-transferrin was incubated with 
59Fe in a molar ratio of 1 to 1.5. Bi-bi Tf and rhTf were incubated with 59Fe in a molar 
ratio of 1 to 3 (see 2.4). 
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5.2.3 Detennination of recombinant transferrin binding 
Recombinant transferrin binding studies were performed as described in detail in 
2.5.2. In short, approximately 4 days before the actual experiment the cells were disse-
minated in either 35 mm cell culture cluster dishes (Costar) or 40 mm glass wells. The 
binding experiments were performed at O°C. PLC/PRF/S ceIJs were incubated with a 
concentration range of 1251 labeled recombinant Tf for 90 minutes. In a parallel experi-
ment the nonspecific binding was determined by measuring the binding of 1251 labeled 
recombinant transferrin in the presence of a (50 times) excess of commercially obtained 
human serum transferrin (Sigma, further referred to as normal Tf). Following the incuba-
tion the cells were washed with PBS, collected and homogenised by sonication. Samples 
were taken for protein determination (Bradford, 2) and surlace bound radioactivity was 
measured. Binding of the recombinant transferrins was compared to the binding of bi-bi 
Tf. 
5.2.4 Detennination of recombinant transferrin and iron uptake 
Uptake studies were perlormed as described in section 2.5.3. In short, cells were 
incubated with doubly labeled rhTf at concentrations of 3 J.lg or 9 Ilg per ml incubation 
medium and with doubly labeled recombinant half-transferrins at concentrations of 5 J.lg 
per ml incubation medium. Uptake experiments were performed at 37°C. At predetermined 
times the incubation was terminated, the cells were washed with PBS and acetate buffer, 
collected and homogenised. Samples were taken for protein determination. Finally 59Fe 
and 1251 were determined in the samples. 
Uptake of the recombinant transfelTins was compared to the uptake of bi-bi Tf. 
Simultaneously the uptake of iron from the recombinant transferrins was compared to that 
of bi-bi Tf. In a paraIJel experiment the uptake of doubly labeled Tf was determined in the 
presence of a (50 times) excess of unlabeled normal Tf. 
Uptake of rhTf and bi-bi Tf in the presence of 200 flM bathophenan-
throlinedisulphonic acid disodium salt (BPS) was compared to the uptake of these 
transferrins in the absence of BPS. The iron uptake from both transferrins in the absence 
or presence of BPS was also compared. 
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5.3 Results 
5.3.1 Binding experiments 
Determination of the binding capacity of rhTf to its receptor on PLC/PRF/5 cells 
was not possible. The binding of 1251 labeled rhTf in the presence of an excess of nonnal 
unlabeled human transferrin was nearly identical to the binding of 1251 labeled rhTf alone. 
Experiments employing plastic wells without cells showed that rhTf had a high 
affinity for this we11 material. In fact the binding to empty wells was higher than the 
binding to wells containing a monolayer of PLCIPRF/5 cells. The use of glass wells made 
no difference. 
5.3.2 Uptake experiments 
5.3.2.1 Uptake experiments with rhTf 
Uptake experiments were done with doubly labeled rhTf in a concentration of 3 
and 9 ~g/ml medium. More 125I1~g cell protein was detected in the experiment with the 
highest concentration (results not shown). 
With respect to rhTf uptake, no appreciable difference was found in the amount of 
detected 1251 per ~g cell protein, between cell incubations with rhTf (3 ~g/ml) in the 
absence or presence of an excess of unlabeled nonnal Tf (results not shown). 
With respect to iron uptake, incubation with 9 Ilg rhTf/ml medium compared to 
incubation with 3 Ilg rhTf/ml medium results in a higher iron uptake per Ilg cell protein 
(fig. I). The iron uptake of bi-bi Tf, however, is many times higher. Fig. I also shows that 
the 59pe uptake from rhTf (3 Jlg/ml) is clearly much lower in the presence of an excess of 
normal diferric Tf. 
PLC/PRFI5 cells incubated with rhTf (9 ~g/ml) in the presence of 200 ~M BPS 
still show a considerable iron uptake compared to PLC/PRFI5 cells incubated with rhTf (9 
~g/ml) alone. We obtained similar results with bi-bi Tf (fig. 2). 
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5.3.2.2 Uptake experiments with rhTjl2C and rhTJl2N 
With respect to half-transferrin uptake, no difference could be demonstrated in the 
detected amount of 1251 after incubation with the 1251 labeled half-transferrins compared 
to incubation with the 1251 labeled half-transferrins in the presence of nOlmal unlabeled 
Tf (results not shown). 
However, with respect to the uptake of iron, a difference was seen between the two 
recombinant half-transferrins. The amount of detected 59pelllg cell protein after incubation 
with doubly labeled rhTf12N is similar to the detected amount 59pe after incubation with 
rhTf12N in the presence of an excess of normal Tf. Regarding rhTf12C, the amount of 
detected 59pe/llg cell protein after incubation in the absence of an excess of nonnal Tf is 
much higher, compared to incubation with rhTf/2C in the presence of an excess of normal 
Tf. Furthermore, the amount of detected 59Fe/[lg cell protein after incubation with rhTfI2C 
is several times higher than after incubation with rhTfl2N (fig. 3). 
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Figure 1. 59Fe uptake by PLC/PRFIS cells. 
+ 
Legend: +: bi-bi Tf (3 ~g/ml); II: rhTf (9 ~g/ml); .: rhTf (3 ~g/ml); 0: rhTf (3 ~g/ml) + 
50 times excess of normal Tf. 
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Figure 2. 59Fe uptake by PLCIPRF/5 cells in the presence or absence of 
bathophenanthrolinedisulphonic acid disodium salt (BPS). 
Legend: +: bi-bi Tf + BPS; .: bi-bi Tf - BPS; 0: rhTf + BPS; +: rhTf - BPS. 
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5.4 Discussion 
The binding of 1251 labeled rhTf in the presence of a (50 times) excess of normal 
unlabeled human Tf being nearly identical to the binding of 1251 labeled rhTf alone, 
indicates a high aspecific binding of rhTf. This presumption was confirmed in our 
experiments with empty wells. 
The high nonspecific binding of rhTf to the cells and the wall of the wells is an 
unusual feature. The lack of carbohydrates in rhTf being responsible for the increased 
nonspecific binding can not be ruled out in this context. On the other hand, it could be 
attributed to properties of sub populations of recombinant transferrins with abnormal con-
formations (due to ineffective refolding) inside the proper population. This is in line with 
the observation that rhTf shows several bands on a native PAGE (fig. 2A and 2B, chapter 
4), indicating that after refolding several subpopulations arise with different physiochemi-
cal characteristics, Since only a small portion of the refolded rhTf has a molecular mass 
deviating from the expected value (fig, 3, chapter 4), a difference in molecular weight can 
not account for all the differences seen on the native PAGE. Therefore it is very likely 
that these physiochemical differences are caused by various conformations of the refolded 
transferrin. Probably both refolded half-transferrins are similarly affected. 
With respect to rhTf uptake, no difference was found between incubations with or 
without an excess of unlabeled nOlmal Tf. This, like in our binding experiments, is an 
indication that rhTf shows a strong nonspecific adherence. 
For running proper uptake experiments, it is of importance that the receptors on the 
cell surface are constantly saturated, Regarding Tf uptake experiments, concentrations of 3 
!-lg Tf/ml incubation medium meet this requirement. Obviously, for our renatured rhTf, this 
concentration is bound to be higher, because we do not expect the total amount of the rhTf 
to be renatured in its native (receptor binding) conformation. Receptor saturating 
conditions can be derived from binding experiments. Unfortunately, rhTf binding studies 
showed inconclusive results (see 5.3,1). 
Therefore we decided to perform an initial uptake experiment using 2 concentra-
tions of doubly labeled (59Fe and 1251) rhTf viz., 3 I'gimI or 9 I'gimJ. Iron uptake from 
the higher concentration (9 !-lg/ml) rhTf exceeded the iron uptake from the lower 
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concentration (3 ~g/ml) rhTf by PLC/PRF/5 celIs (fig. I), indicating that a concentration 
of 3 ~g/ml of rhTf indeed does not saturate the transferrin receptors continuously. By 
increasing the concentration it might have been possible to detelmine the concentration at 
which the receptors are continuously saturated, because theoretically the increase in iron 
uptake levels off when this concentration has been exceeded. 
Unfortunately, due to shortage of recombinant transferrin it was not possible to 
incubate hepatoma cells with a series of concentrations higher then 9 ~g/ml. At any rate, 
figure 1 also shows that iron uptake from recombinant transferrin is strongly decreased in 
the presence of an (50 times) excess of normal Tf, suggesting that the iron uptake of 
recombinant transferrin is a saturable process in line with receptor mediated endocytosis of 
rhTf. 
Iron uptake from Tf by hepatocytes without internalization of the carrier protein 
has been described (3,4,5). It has been suggested that diferric Tf binds to its receptor in 
close proximity to NADH differic Tf reductase. The iron bound to Tf is reduced and the 
ferrous ions are transported through the plasma membrane. To detennine whether iron 
uptake from rhTf by this mechanism plays any significant role, iron uptake in the presence 
of 200 ~M BPS was defined. BPS forms a complex with ferrous iron, preventing it 
passing the plasma membrane. There is still a substantial iron uptake in the presence of 
BPS (fig. 2), so probably a major part of the iron uptake from rhTf is by means of 
receptor mediated endocytosis of rhTf. 
With both our recombinant half-transferrins, no uptake of rhTfI2C or rhTfI2N could 
be demonstrated. The 1251 uptake measured after incubation with an excess of normal 
unlabeled Tf was nearly equal to the amount, measured after incubation without an excess 
of normal unlabeled Tf. So the nonspecific adherence of both rhTf/2C and rhTf/2N seems 
to be very high. In our work, this high nonspecific adherence can easily mask any uptake 
of the recombinant half-transferrins. 
As can be concluded from figure 3, there is a striking difference in iron uptake 
from rhTfI2C and rhTfI2N, rhTfI2C being much higher. Incubating with rhTf!2N in the 
presence or without an excess of normal Tf gave similar results, so no specific uptake 
from rhTfl2N was demonstrated. However, the difference in iron uptake from rhTf!2C in 
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the presence or without an excess of nonnal Tf indicates a specific iron uptake from 
rhTf12C. These results are in line with data from literature (6) in which experiments have 
been run with half-transferrins which were produced by digestion of Tf with thermolysin. 
The latter procedure probably leads to properly folded half-transferrins, in which the C-
terminal half-transferrin is still glycosylated. As reported in this experiment, N-terminal 
half-transferrin is unable to bind to Tf receptors. The C-terminal half Tf, however, can 
bind to Tf receptors and can therefore enter cells by means of receptor mediated endocyto-
sis (and donate iron). 
In contrast, our results with rhTfl2N do not agree with a recent paper of 
Thorstensen ef al. (7). These authors report that N-tenninal half-transferrin (obtained the 
same way as described in (6)) is able to donate iron to rat hepatocytes through an 
unknown mechanism in which presumably pinocytosis plays a role without the interaction 
of transferrin receptors. We could not confirm iron donation from N-terminal half-trans-
ferrin using recombinant N-terminal half-transferrin. 
In general, the few available studies examining iron uptake from aglyco Tf indicate 
that nonglycosylated Tf tends to decreased iron donation compared to normal transferrin 
(8,9). Before this can be confirmed using refolded recombinant aglycotransferrins, more 
data should be available on the different conformations that arise after refolding. When it 
is possible to perform studies with pure samples of correctly folded recombinant 
transferrins, it will be possible to investigate the influence of the transferrin 
oligosaccharides on the function of this protein. 
At the present state of the art, we merely know that refolded rhTf can donate iron 
to hepatoma cells, probably after uptake by means of receptor mediated endocytosis. 
Regarding the recombinant half-transferrins, rhTf!2C is able to donate iron to hepatoma 
cells, and no iron donation from rhTfl2N could be demonstrated. 
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5.5 Summary 
In this chapter the biological activity of recombinant transferrin, recombinant c-
terminal and recombinant N-terminal half-transferrin after refolding is described. Insight in 
the functionality of the refolded recombinant proteins was obtained by performing 
transfelTin binding- and iron uptake studies. 
Receptor mediated Tf (and iron) uptake is a very specific process depending on a very 
specific conformation of the Tf molecule. 
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6.1 Introduction 
In Western society alcohol abuse has a prevalence of between 10 to 15% in the 
population. Within this small section there is a striking variability in an individual's 
response to the chronic effects of excess alcohol intake. A variety of symptoms will be 
exhibited by these subjects ranging from life threatening alcohol induced liver damage or 
brain damage, to cardiovascular disturbances, myopathy or merely skin disorders. Alcohol 
abuse is now recognized to precipitate or exacerbate certain cutaneous diseases in 
particular psoriasis (1) and these skin problems appear to occur as an early manifestation, 
often before evidence of classical hepatic toxicity is apparent. A recent survey of 100 
psoriasis patients attending the Dermatology Out Patient Department of a London 
Teaching Hospital, showed that 39% of these patients were drinking in excess of 
recommended guidelines (2). Furthermore the psoriasis improved when the patient ceased 
alcohol intake. Similarly in patients with alcohol induced myopathy, which occurs in 70% 
of alcohol abusing subjects (3) there is amelioration of the myopathy on cessation of 
alcohol intake. 
There have been extensive investigations to identify a biochemical marker of 
alcohol abuse which could be used firstly to assess the extent to which the patient is 
abusing alcohol, secondly recognise which patients are at particular risk of alcohol abuse 
(4) and perhaps more importantly whether continuing abuse of alcohol could progress to 
life threatening problems. Many biochemical markers have been studied e.g. HLA 
antigens, blood group antigens, platelet monoamine oxidase, erythrocyte macrocytosis and 
gamma-glutamyl transpeptidase (5), but each has been lacking in both precision and 
reliability for their ability to identify patients abusing alcohol. 
Glycosylation of secreted proteins is often found to vary in disease conditions, 
although their mode of action and pathogenesis are not well understood. Alterations in the 
sialic acid content of transferrin (Tf) occurs in subjects severely abusing alcohol. The di-
(2-Si), mono- (I-Si), and asialo forms of human Tf are increasing (6). These Tf subfrac-
tions with reduced sialic acid content are also referred as carbohydrate deficient transferrin 
(eDT). There is now an increasing scientific literature indicating that this index shows the 
necessary specificity and precision as a marker of gross alcohol abuse. However there 
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have been only a few studies of individuals who abuse alcohol to a limited degree, their 
intake being above the recommended guidelines, but nevertheless show an averse reaction 
which necessitates medical attention. 
In this chapter we discuss the degree of sialylation of Tf in male and female 
subjects with psoriasis who have an intake of alcohol above the recommended guidelines, 
and compare this with another group of psoriasis patients with no evidence of abusing 
alcohol (7). Comparison of these results are made with patients with alcohol-induced 
myopathy and with two other groups, where gross tissue damage has been induced by 
excessive alcohol intake, namely liver disease and brain damage. 
6.2 Materials and Methods 
6.2.1 Selection of Patients 
0) Psoriasis patients 
Patients (n=52) were recruited from the Dermatology Out-patients at King's College 
Hospital as part of a prospective study examining the relationship between alcohol 
consumption and skin disease. Drinking habits were assessed by means of a 
frequency/quantity questionnaire, as such structured questionnaires have been shown to be 
a more sensitive indicator of alcohol misuse than standard biochemical screening (8). Of 
these 52 patients, 4 female and 18 male patients were identified as heavy drinkers (mean 
intake of alcohol/week 35.6 units ± 16.7). One unit represents the amount of ethanol in 
one alcoholic drink (8-10 g). 
(ii) Patients with alcohol induced liver cirrhosis or myopathy 
Patients with alcohol induced cirrhosis (n=6) or alcoholic myopathy (n=6) which 
had been confirmed by liver and muscle biopsy, respectively, and were consuming alcohol 
up to the time of the blood sampling, (mean intake of alcohol/day 36.9 units ± 3.8) were 
selected as positive controls for alcohol abuse. 
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(iii) Patients with alcohol induced brain damage 
Patients with alcohol induced brain damage (n=6), identified by biochemical 
(altered parameters for the erythrocyte transketolase enzyme) and cognitive test. Such 
subjects were not necessarily drinking at the time of the blood sampling. 
(iv) Control subjects 
Control group of subjects from healthy individuals was recruited for the study, with 
an age range comparable to the patient groups, who consumed only small quantities of 
alcohol per week « 4 units). 
6.2.2 Detel7nination of the transferrin sialo-variants 
Sera were prepared from the blood specimens collected from the different patient 
groups, and stored at -200 C until analysis. Isoelectric focusing was run in PhastSystem 
with Immobiline DIY Plate pH 4-7 (Parmacia LKB, Uppsala, Sweden). A part of this gel 
was cut out to the same size as PhastGel, to obtain a pH-gradient between the electrodes 
of 5.0-6.0. lsoelectric focusing and staining of the gels were performed as described in 
chapter 2 (2.7.2 and 2.7.3). 
6.2.3 Statistical Analyses 
For the statistical analyses an analysis of variance (ANOY A) with protected Tukey 
't'test was performed. 
6.3 Results 
Table I shows the results for the different isoforms of Tf in the sera of patients 
with psoriasis. There were changes in the percentages of isoforms of the highly sialylated 
forms of Tf present, particularly 5-Si, while there were significant increases in the 
percentage of the 2-Si forms present in the sera of psoriasis patients, both male and 
female, abusing alcohol, by comparison to psoriasis patients who did not. In addition the 
3-Si form also increased in the psoriatic patients abusing alcohol. In each of the patient 
groups where excessive amounts of alcohol had induced liver, brain or muscle damage, 
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Isoforms of transferrin (%) in sera of psoriasis patients not abusing alcohol 
7-Si 6-Si 5-Si 4-Si 3-Si 2-Si 
Male 0=20 0.7 3.9 20.9 63.9 7.0 2.7 
±OA ±1.1 ±2.9 ±4.6 ±2.3 ±l.3 
Female 0.5 4.9 23.6 60.8 7.1 3.0 
0=18 ±0.2 ±1.1 ±3.3 ±4.0 ±2.3 ±1.l 
Isoforms of transferrin (%) in sera of psoriasis patients abusing alcohol. 
7-Si 6-Si 5-Si 4-Si 3-Si 2-Si 
Male 0=10 0.6 4.2 2004 63.9 7.5 304' 
±OA ±0.9 ±2.2 ±5.5 ±3.1 ±2.7 
Female old 4.5 23.8 56.9 10.2' 4,7** 
0=4 ±1.8 ±3.8 ±6.8 ±1.8 ±0.7 
Isoforms of transferrin (%) in sera of alcohol misusers with myopathy, liver or brain 
damage 
7-Si 6-Si 5-Si 4-Si 
Myopathy old 3.1 17.7 64.2 
0=6 ±l.l ±6.2 ±5.7 
Liver old 5.2 21.0 59.1 
damage ±IA ±3.9 ±5.3 
0=6 
Brain old 3.2 20.2 63.0 
damage ±0.3 ±2A ±3.1 
0=6 
Isoforms of transferrin (%) in sera of control subjects. 
7-Si 6-Si 5-Si 4-Si 
0=10 old 4.9 25.6 60.6 
±IA ±1.7 ±2.6 
Table 1. Results are mean ± standard deviation. 
Statistical significance by ANOV A with protected Tukey 't' test. 
*P<0.05 *'P<O.O 1 
n/d: not determined 
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3-Si 2-Si 
7.3 4,5** 
±1.8 ±2.3 
7.7 6.6*' 
±2.3 ±4.9 
8.3 504** 
±1.5 ±3.0 
3-Si 2-Si 
6.6 2.2 
±1.8 ±0.5 
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significantly increased percentages of di-sialo Tf were found. This increase in the 2-Si 
isoform of Tf appeared to be at the expense of the 6-Si and 5-Si isofonns of Tf which 
were both reduced. 
6.4 Discussion 
It is now well established that chronic ingestion of alcohol impairs the integrity of 
glycoproteins and glycoIipids in liver, brain erythrocytes and intestine. This study confir-
med the elevated levels of di-sialylated Tf in alcoholic patients with dependency, with 
either alcoholic liver disease or brain damage. In addition this study also showed that 
patients with either myopathy or psoriasis, in whom dependency on alcohol was not 
necessarily apparent, the 2-Si Tf isoform was increased. 
One of the principal criticisms of many of the reported studies of alcohol abuse has 
been the problem of retrospective self-reporting of alcohol consumption. In this present 
study we have attempted to correct this error of other studies by using a structured 
questionnaire. 
Elevated amounts of carbohydrate deficient transferrin (CDT), notably the di- and 
tri-sialylated forms, were first identified by Stibler and Kjellin (9) in the cerebrospinal 
fluid and serum of alcohol misusers with cerebellar tremor. The explanation for the altered 
isoforms of Tf in alcoholic subjects with physical damage is possibly caused by alcohol 
interfering with the metabolism of glycoconjugates. Chronic alcohol misuse alters the N-
acetyl-neuraminic acid (sialic acid) content of Tf resulting in increased serum concentrati-
ons of sialic acid-deficient Tf with isoforms with an isoelectric point (pI) of 5.7 and 5.9. 
The function of the sialic acid-deficient Tf in alcohol misusers remains unclear. Trans-
ferrin, the major serum iron transport protein is metabolised more rapidly (although unlike 
all other glycoproteins, not by the liver) following alcohol abuse until the development of 
cirrhosis (10). Loss of the carbohydrate chain does not appear to alter its catabolism. CDT 
can bind to two sets of receptors, the hepatic asialoglycoprotein receptors as well as to 
transferrin receptors. The former leads to degradation while the latter does not, suggesting 
that there is some compensatory mechanism activated by alcohol to restore Tf turnover to 
normal. 
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Carbohydrate deficient transferrin (CDT) has been suggested to show a high 
sensitivity and specificity (>70%) for alcohol misuse, particularly in patients with liver 
cirrhosis or recently consuming large amounts of alcohol. The most critical unresolved 
question is exactly what parameters are needed to alter the CDT levels, firstly how much 
alcohol needs to be consumed, what is the duration of the drinking history needed and 
lastly does there have to be associated tissue damage. In the few studies where CDT 
values have been assayed in healthier and younger alcohol misusers with shorter drinking 
histories, eDT has been shown to have a sensitivity of less than 30% for alcohol misuse 
(II). Furthermore only 20% of normal subjects consuming 60 g alcohol/day for 3 weeks 
in another study, showed eDT levels that exceeded the upper normal level (12). Such 
results have led to the belief that there must be some degree of physical damage before 
eDT is elevated (11,13). 
CDT was shown to have a lower specificity and sensitivity for alcohol abuse by 
females compared to alcohol abuse by males (14), although this was not confirmed in this 
present study. The few psoriasis patients abusing alcohol showed highly elevated amounts 
of 2-Si. 
A study of 439 treated hypertensives showed that there was a positive relationship 
between CDT and high alcohol intake, the sensitivity of the test being 87%, but there were 
a considerable number of false positives (15). Serum eDT concentrations were also 
associated with insulin sensitivity (16) indicating that factors related to insulin may be 
operative. 
It remains unclear as to whether excessive alcohol consumption actually alters iron 
homeostasis. It is clear that alcohol will increase gut permeability, and possibly increase 
absorption of iron into the enterocyte (17). Whether this iron is actually utilised internally 
is unknown. There was a two fold increase in the mean concentration of serum ferritin in 
the psoriasis group associated with increased alcohol intake by comparison to the non-
drinking psoriasis group, (165.9 ± 146 v 87.8 ± 67.5 ng/l), although only five of the 
former group had values for ferritin increased to the normal ranges (unpublished results). 
Other diseases where there are perturbations of iron metabolism have been investigated to 
asceltain whether changes also occur in the Tf isoforms. Patients with haemochromatosis 
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(increased serum ferritin levels) showed marginally increased eDT values, particularly 
during phlebotomy (18) although the values were not necessarily elevated above the 
reference ranges. Iron deficiency caused either as a normal physiological response to 
pregnancy (decreased serum ferritin) or as a result of chronic inflammation (increased 
serum fen'itin) as observed in rheumatoid arthritis patients, showed a tendency for an 
increase in the highly sialylated transfen'ins, rather than the di-sialo Tf which maintained a 
constant value (19). 
Earlier methods used non-quantitative methods of isoelectric focusing as reported 
in this present communication, while more recently quantitative methods have been 
developed to separate Tf components above pI 5.65 by micro-anion exchange chromato-
graphy (6) followed by RIA to evaluate eDT. This method has been further modified by 
adoption of a different elution buffer that achieves a more stable anion exchange 
chromatography of isotransferrins. Studies which have compared isoelectric focusing and 
anion exchange chromatography have found a somewhat higher sensitivity and specificity 
with isoelectric focusing immunofixation than with anion exchange chromatography-RIA 
method (e.g. 20·23). In addition the analysis of eDT by anion exchange chromatography 
will also suffer from the fact that total Tf is somewhat variable among individuals 
regardless of whether or not they are alcoholic; furthermore the presence of anticoagulants 
in the sample may interfere with the chromatography method. 
These studies have indicated that eDT is a sensitive marker of alcohol intake in 
subjects not necessarily showing gross physical damage. eDT may therefore prove to be 
an effective marker of early alcohol misuse, possibly before the onset of irreversible organ 
damage. Although other markers of alcohol abuse show a high specificity and sensitivity 
either alone or in combination (such as the determination of apo A-II, plasma y-GT, 
plasma uric acid and MeV (24)), the simplicity of a single test to assess alcohol abuse 
remains attractive. Further studies are required to identify what role these different 
isoforms of Tf may play within biochemical systems. 
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6.5 Summary 
The different isoforms of Tf have been quantitated by isoelectric focusing of the 
sera of psoriasis patients with and without a history of abusing alcohol. In both male and 
female subjects abusing alcohol there were significant increases, P<O.05 and P<O.O I 
respectively, in the 2-sialylated forms by comparison to either psoriasis subjects not 
abusing alcohol or control subjects. Other groups of patients who showed alcohol induced 
tissue damage, Le. liver, brain or muscle, used as positive controls, similarly showed 
significant increases in the 2-sialylated forms, P<O.OI in each group, by comparison to 
controls. These results substantiate the current use of carbohydrate deficient Tf as a 
sensitive marker of alcohol abuse. 
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Chapter 7 
7.1 Introduction 
During the last decade, there has been an increasing interest in the significance of 
protein glycans. Protein glycosylation is the most common post-translational modification 
of newly synthesized proteins. All membrane proteins of higher organisms and most 
secretory proteins (e.g. transferrin, Tf) are glycosylated. Glycoproteins can also be found 
in the cytoplasm and nucleus of cells (1). 
The conservation of carbohydrate units on glycoproteins during evolution indicates 
that these structures are of vital importance for a normal function of these proteins. 
However, no universal function could be attributed to the glycans, but it is generaIly 
accepted that the oligosaccharide moieties of glycoproteins can alter the physiochemical 
properties of the molecules. These alterations can result in an increased solubility and in 
an increased stability of the glycoproteins, against proteolysis as well as thermal stress (2-
5). Protection of glycoproteins against proteolytic enzymes by the glycans can be effected 
either by increased rigidity of the protein (due to carbohydrate-carbohydrate or 
carbohydrate-protein interactions) or by sterically shielding susceptible sites. Glycans can 
nearly completely cover proteins as can be seen with human alpha-I-acid glycoprotein (6). 
Another general function of the glycans could be to support the folding of the nascent 
polypeptide chain and to stabilize the conformation of the glycoprotein (2). In fact, any 
function depending on the conformation of the glycoproteins may be affected by changes 
in the glycan chains. Glycans can also increase the solubility of glycoproteins, especially 
through the effect of the negative charges of the sialic acid residues and sulphate groups. 
Glycans are also known to influence the biological properties of glycoproteins, 
such as the regulation of intracellular transport (7,8) and the determination of the lifetime 
of glycoproteins in the circulation (9,10). Modulation of the activity of enzymes, hormones 
and receptors has also been described for several glycoproteins (2,11,12). However, in 
some cases these changes in activity could merely be a direct result of changes in the 
protein conformation as already discussed above. 
The importance of glycans for the function of glycoproteins has been reviewed in 
several publications (2,3,4,13). It can be concluded from these publications that no 
univocal function can be attributed to the glycans of glycoproteins. Clearly the 
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oligosaccharide moieties have different effects on different glycoproteins, and in many 
cases even no effect at all can be detected. 
7.2 The importance of the glycans for the function of transferrin 
No function could be attributed to the Tf glycans so far. The glycans play no role 
in the transport of Tf during synthesis (7,8), as has been reported for other glycoproteins. 
The glycans of Tf can not be of vital importance for the folding of Tf, otherwise aglyco 
Tf would not be found occurring in the serum of CDG syndrome patients, but would 
probably form aggregates during synthesis. Presumably the glycans of Tf are not of 
essential importance for Tf, given that Tf of several fish species of the family Cyprinidae 
is nonglycosylated (14,15). 
7.3 The clinical significance of the transferrin gIycans 
The Tf glycans play a significant role in the diagnosis of the Carbohydrate 
Deficient Glycoprotein (CDG) syndrome (16). Excessive alcohol intake changes the 
distribution of the different sialo variants of Tf in the serum towards an increase of the 
lower sialylated transferrin subfractions. First described by Stibler (17), numerous studies 
have since been published on the use of Tf as a marker for alcohol abuse in certain 
subpopulations (for instance in combination with certain clinical signs or symptoms, 18-
23). Most of these studies, however, concentrated on gross alcohol abuse. 
7.4 Production of aglycotransferrin 
The purpose of the research described in this thesis was to obtain some insight in 
the significance of the glycans on Tf for the function of this protein. Lately, much 
attention has been directed towards the specific changes in glycan microheterogeneity of 
Tf during the course of certain diseases and pregnancy (24-35). Assuming these changes 
represent an adjustment of the Tf function to altered (patho )physiological changes, it 
would be very interesting to learn more about the primary function of the Tf glycans. 
Since the major function of Tf is the transport of iron to the various cell types requiring 
this metal, our efforts were focused on the influence of the Tf glycan chains on this 
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function. In order to assess the importance of the Tf glycans to receptor binding and 
uptake of Tf, the availability of aglyco Tf is essential. 
Attempts were made to produce aglyco Tf by two different methods; by expression 
in Escherichia coli resulting in nonglycosylated rhTf and by step-wise digestion of the 
glycan chains using the proper enzymes. Both methods have been extensively described in 
the preceeding chapters. 
In short, expression of human Tf in E. coli resulted in a nonglycosylated form of 
this protein, deposited by the bacterial metabolism in a denatured and reduced state in so 
called inclusion bodies. The inclusion bodies were isolated and dissolved. Subsequently 
the recombinant Tf (rhTf) was refolded under appropriate conditions. Recombinant C-
terminal and N-terminal half-transferrins (rhTfl2C and rhTfl2N) were produced in a 
similar way. 
Production of aglyco Tf by step-wise digestion of the Tf glycans using the proper 
enzymes, proved to be impossible. Attempts resulted in partially deglycosylated Tf, in 
other words Tf lacking only the three distal sugar residues of its glycans. 
A third source of aglyco Tf proved to be serum obtained from a patient suffering 
from the Carbohydrate Deficient Glycoprotein (CDG) syndrome. Regretfully only minute 
amounts of aglyco Tf could be obtained from this source. 
7.5 Biological properties of aglycotransferrin and partially deglycosylated transferrin 
Binding and uptake studies were performed with aglyco Tf isolated from a patient 
suffering from the CDG syndrome. Tf binding studies comparing aglyco Tf with normal 
glycosyJated Tf, revealed that the absence of the Tf glycans does not influence the affinity 
of this protein for its receptor (chapter 3, fig. 4). 
Tf uptake studies showed that agJyco Tf reached a lower steady state in 
PLC/PRF/5 cells then fully glycosylated Tf (chaptcr 3, fig. 6). Likewise the iron donation 
by aglyco Tf was decreased compared to fully glycosylated Tf (chapter 3, fig. 6). 
Enzymatical digestion of the three most distal sugar residues (sialic acid, galactose 
and N-acetyl glucosamine, see chapter 3, fig. 1) of the Tf glycan chains of normal 
glycosylated Tf did not influence the affinity of Tf for its receptor (chapter 3, fig. 4). This 
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partial deglycosylation did not have any influence on the Tf and iron uptake, when 
compared to fully glycosylated Tf. 
With respect to aglyco Tf, it can be concluded that the Tf glycans do influence the 
uptake of Tf and iron by cells without affecting the affinity of the protein for its receptor. 
With respect to partially deglycosylated Tf, it can be concluded that the antennae of the Tf 
glycans do not influence the uptake of Tf and iron. 
These results fit in a hypothetical model in which the glycan chains of Tf are 
involved in the regulation of the endocytosis of the Tf-transferrin receptor complex. The 
antennae of the glycan chains do not have any influence on this regulation, since their 
removal does not alter the endocytosis of Tf. This hypothesis implicates that Tf binding by 
the Tf receptor is necessary for the receptor to be endocytosed. Although this has been 
reported to be true (35), this matter is stilI a point of discussion. 
7.6 Biological properties of recombinant aglycotransferrin and recombinant halfv 
transferrins 
Tf binding studies comparing rhTf to nonnal glycosylated Tf were inconclusive, 
because rhTf showed a very high aspecific binding. For the same reason Tf uptake studies 
were also impossible to assess. 
Iron uptake studies comparing fully glycosylated Tf with rhTf showed a reduced 
uptake of iron from the latter protein. This reduction was much stronger than that seen 
with the iron uptake from aglyco Tf, isolated from serum of a CDG syndrome patient. It is 
very likely that the reduced uptake is due to the lack of the glycan chains and to the fact 
that a substantial part of the refolded rhTf has a misfolded conformation (chapter 5). 
Therefore rhTf will only be suitable for comparative studies as soon as more data are 
available on the conformations that arise during refolding, and as soon as the correctly 
folded rhTf can be isolated from the misfolded conformations. 
Iron uptake studies comparing rhTfI2C and rhTf!2N to normal glycosylated Tf 
showed that of both recombinant transferrins, only rhTf12C is capable of donating iron to 
hepatoma cells. As for rhTf, more data on the conformations of both half-transferrins after 
refolding are needed, before any comparative studies can be performed. Only then we can 
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try to elucidate the question whether the Tf glycans are of vital importance to the 
(function of the) protein. 
7.7 Conclusions 
It can be concluded from our research that: 
(1) Absence of the Tf glycans on Tf does not influence the affinity of this protein for 
its receptor. 
(2) Uptake of aglyco Tf by hepatoma cells (PLC/PRF/5 cell line) is decreased 
compared to fully glycosylated Tf. 
(3) Iron uptake from aglyco Tf by PLC/PRF/5 cells is decreased compared with fully 
glycosylated Tf. 
(4) Recombinant human Tf produced by Escherichia coli and deposited in inclusion 
bodies can be renatured to a water soluble and iron-binding form. 
(5) This renatured recombinant human Tf is capable to donate iron to PLC/PRF/5 cells 
(human hepatoma cells). 
(6) Renatured recombinant human C-tenninal half-transferrin (rhTf!2C) is also capable 
to donate iron to PLC/PRP/5 cells. Renatured recombinant human N-tenninal half-
transfelTin, however, is not capable to donate iron to PLC/PRP/5 cells. 
(7) Carbohydrate-deficient Tf can be used as a marker for the detection of moderate 
alcohol abuse in psoriasis patients. 
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Chapter 8 
8.1 Summary 
Within species there is an important difference in the glycosylation of serum 
transferrin (T£). The number of glycans on Tf varies from zero (in certain fish species) to 
two (in humans). 
In humans the Tf glycans can be of the bi-antennary, tri-antennary or even tetra-
antennary type. These differences in the glycans contribute to the so called 
micro heterogeneity of Tf. The distribution of transferrins, differing in their glycan 
composition, is considerably constant in humans. However, {patho )physiological changes 
(e.g. pregnancy, alcohol abuse, carcinomas, rheumatoid arthritis) result in characteristic 
changes in the glycan composition of Tf. No specific function could be attributed to the Tf 
glycans so far. In order to detennine the biological significance of the Tf glycans, the 
function of normal Tf should be compared to the function of nonglycosylated Tf. 
This thesis describes the isolation and renaturation of nonglycosylated recombinant 
Tf produced in Escherichia coli and the production of partially deglycosylated Tf by 
incubating Tf with the proper exoglycosidases. Nonglycosylated Tf was also obtained from 
serum of a patient suffering from the Carbohydrate Deficient Glycoprotein (CDG) 
syndrome. The binding of the abnormally glycosylated transferrins was compared to the 
binding of the normally glycosylated Tf. The uptake of these abnormally glycosylated 
transferrins by hepatoma cells was compared to the uptake of normally glycosylated Tf by 
these celis, Similarly the iron donation was compared, 
Finally this thesis describes the possibility to use the specific changes of the Tf 
microheterogeneity as a marker for moderate alcohol abuse. 
Chapter J 
This chapter gives an overview of: 
(a) The function of iron, 
(b) The siderophilins. 
(c) General considerations on glycoproteins. 
(d) Transferrin. 
(e) The significance of transferrin glycans, 
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(f) Production of aglycotransfen·in. 
(g) Renaturation of recombinant proteins. 
(h) Iron donation by transferrin. 
Chapter 2 
This chapter describes the general techniques that contributed to the experimental results 
discussed in this thesis. 
Chapter 3 
In this chapter the receptor binding of partially deglycosylated Tf and nonglycosylated Tf 
(obtained from serum of a patient suffering of the CDG syndrome) is compared to the 
receptor binding of normally glycosylated Tf. Uptake of these transferrins with abnormal 
glycosylation by hepatoma cells is compared to uptake of normally glycosylated Tf. Iron 
donation is compared in a similar way. 
Chapter 4 
The isolation and renaturation of recombinant human transferrin (rhTf), recombinant 
human C-terminal half-transferrin (rhTfI2C) and recombinant human N-terminal half-
transferrin (rhTf/2N) produced in Escherichia coli is described in this chapter. The amino 
acid composition of the recombinant transferrins is compared to the amino acid 
composition of normal human Tf. 
The iron binding capacities of the recombinant transferrins is detennined by 59pe labeling, 
absorption spectrophotometry and EPR spectrometry. 
Chapter 5 
In this chapter receptor binding and uptake of rhTf, rhTf/2C and rhTf!2N are compared to 
receptor binding and uptake of normally glycosylated Tf. Iron donation by the recombinant 
transferrins is compared to iron donation by normal human Tf. 
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Chapter 6 
The use of changes in the Tf microheterogeneity as a marker for moderate alcohol abuse 
is discussed in this chapter. 
Chapter 7 
In this chapter the conclusions of the experimental results described in this thesis are 
discussed. Furthermore a hypothesis on the function of the Tf glycans is proposed. 
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8.2 Samenvatting 
De mate van glycosylering van serum transferrine (Tf) is duidelijk verschillend bij 
diverse diersoorten. Het aantal aan Tf gebonden glycanen varieert van geen enkele (bij 
bepaalde vissoorten) tot twee (bij mensen). 
Aan humaan Tf kunnen zoweI bi-antennaire, tri-antennaire als telra-antennaire 
glycanen gevonden worden. Deze verschillen in glycosylering dragen bij tot de 
zogenaamde micro-heterogeniteit van Tf. De verdeling van Tf met een verschillende mate 
van glycosylering is vrij constant. Bij bepaalde (patho)fysiologische veranderingen (bijv. 
zwangerschap, alkoholmisbruik, bepaalde carcinomen, rheumato'ide arthritis) worden 
specifieke veranderingen in deze verdeling van glycanen gezien. Het is nog niet bekend of 
deze glycanen een funktie vervullen. Om dit te onderzoeken, is het noodzakelijk te 
beschikken over Tf zander deze glycanen (aglyco Tf). 
In dit proefschrift worden de zuivering en renaturatie van recombinant Tf 
beschreven. Dit recombinant Tf (geproduceerd in Escherichia coli bacterien) bevat geen 
glycanen. Tevens wordt de gedeeltelijke afbraak van de gIycanen van humaan Tf met 
behulp van enzymen beschreven in dit proefschrift. Aglyco Tf werd ook verkregen door 
dit eiwit te isoleren uit serum van een patient met het Carbohydrate Deficient Glycoprotein 
(CDG) sydroom. 
De receptor binding van de hierboven genoemde transferrines werd vergeleken met 
de receptorbinding van normaal geglycosyleerd Tf. De opname van deze transfen'ines (en 
ijzer) door hepatoma cell en werd vergeleken met de opname van normaal geglycosyleerd 
Tf door hepatoma cellen. 
Tenslotte wordt het gebruik van de specifieke verandering in de Tf micro-heterogeniteit als 
een marker voor alkoholmisbruik beschreven. 
Hoofdstuk 1 
In dit hoofdstuk worden achtereenvolgens beschreven: 
<a) De runktie van ijzer. 
(b) De siderophilines. 
(c) Algemene opmerkingen betreffende glycoproteinen. 
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Cd) Transferrine. 
(e) Het belang van de transferrine glycanen. 
(f) Productie van aglycotransferrine. 
(g) Renaturatie van recombinant eiwitten. 
(h) IJzer afgifte door transferrine. 
Hoojdstuk 2 
In dit hoofdstuk worden de technieken vermeld die toegepast zijn en geleid hebben tot de 
onderzoeksresultaten beschreven in dit proefschrift. 
HooJdsluk 3 
In dit hoofdstuk wordt de receptor binding van gedeeltelijk gedeglycosyleerd Tf en aglyco 
Tf (verkregen uit serum van een patient met het CDG syndroom) vergeleken met de recep-
tor binding van normaal geglycosyleerd Tf. De opname van abnonnaal geglycosyleerde 
transferrines wordt vergeleken met de opname van normaal geglycosyleerd Tf. Tevens 
wordt de ijzer afgifte door de verschillende transfen·ines vergeleken. 
HooJdstuk 4 
In dit hoofdstuk worden de zuivering en renaturatie van in Escherichia coli geproduceerd 
recombinant humaan transferrine (rhTf), recombinant humaan C-terminaal half-transferrine 
(rhTf/2C) en recombinant humaan N-terminaal half-transfelTine (rhTfI2N) beschreven. 
De aminozuur samenstelling van de recombinant transferrines wordt vergeleken met die 
van het normale humane Tf. 
Het ijzerbindend vermogen van de recombinant transferrines werd aangetoond met behulp 
van 59Fe, absorptie spectrofotometrie en EPR spectrometrie. 
Hoofdstuk 5 
In dit hoofdstuk worden receptor binding en opname van rhTf, rhTfI2C en rhTfI2N 
vergeleken met receptor binding en opname van normaal Tf. Tevens wordt de ijzer afgifte 
door de recombinant transferrines vergeleken met de ijzer afgifte door normaal 
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transferrine. 
Hoofdsruk 6 
De magelijkheid am veranderingen in de Tf micro-heterogeniteit te gebruiken vaar het 
opsporen van alkaholmisbruik wordt beschreven in dit hoofdstuk. 
Hoofdsruk 7 
In dit hoofdstuk worden de conclusies uit de bovengenaemde hoofdstukken samengevat en 
is een hypothese over de functie van de Tf glycanen opgesteld. 
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